UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549



FORM			10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~December 31, 2022~~June 30, 2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-31321



NAUTILUS, INC.
(Exact name of Registrant as specified in its charter)


Washington						94-3002667
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

17750 S.E. 6th Way

Vancouver, Washington 98683

(Address of principal executive offices, including zip code)

(360) 859-2900

(Registrant's telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, no par value	NLS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [x] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated Filer

☒☐

Non-accelerated filer

☐☒

Smaller reporting company

☐☒

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No [x]

The number of shares outstanding of the registrant's common stock as of ~~February 3,~~August 4, 2023 was ~~31,832,464~~36,089,978 shares.

NAUTILUS, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED ~~DECEMBER 31, 2022~~JUNE 30, 2023


	PART I
Item 1.	Financial Statements	1
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	2422
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	4436
Item 4.	Controls and Procedures	4436

	PART II
Item 1.	Legal Proceedings	4537
Item 1A.	Risk Factors	4537

Item 6.	Exhibits	4638
Signatures		4739

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

NAUTILUS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)


		As of				As of
		December 31, 2022		March 31, 2022				June 30, 2023		March 31, 2023
		(unaudited)						(unaudited)
Assets	Assets						Assets
Cash and cash equivalents	Cash and cash equivalents	$	15,532	$	12,872		Cash and cash equivalents	$	17,326	$	17,362
Restricted cash	Restricted cash	947		1,339			Restricted cash	954		950

Trade receivables, net of allowances of $603 and $598		42,670		61,454
Trade receivables, net of allowances of $550 and $618							Trade receivables, net of allowances of $550 and $618	13,225		21,489
Inventories	Inventories	77,315		111,190			Inventories	39,791		46,599
Prepaids and other current assets	Prepaids and other current assets	12,987		14,546			Prepaids and other current assets	7,914		8,033
Other current assets - restricted, current		3,887		3,887

Income taxes receivable	Income taxes receivable	1,710		1,998			Income taxes receivable	7,235		1,789

Total current assets	Total current assets	155,048		207,286			Total current assets	86,445		96,222
Property, plant and equipment, net	Property, plant and equipment, net	34,144		32,129			Property, plant and equipment, net	30,502		32,789
Operating lease right-of-use assets	Operating lease right-of-use assets	20,033		23,620			Operating lease right-of-use assets	18,009		19,078
Goodwill		—		24,510

Other intangible assets, net	Other intangible assets, net	6,802		9,304			Other intangible assets, net	3,075		6,787
Deferred income tax assets, non-current	Deferred income tax assets, non-current	768		8,760			Deferred income tax assets, non-current	554		554
Income taxes receivable, non-current	Income taxes receivable, non-current	5,673		5,673			Income taxes receivable, non-current	—		5,673

Other assets	Other assets	2,625		2,763			Other assets	1,596		2,429
Total assets	Total assets	$	225,093	$	314,045		Total assets	$	140,181	$	163,532
Liabilities and Shareholders' Equity	Liabilities and Shareholders' Equity						Liabilities and Shareholders' Equity
Trade payables	Trade payables	$	34,966	$	53,165		Trade payables	$	20,527	$	29,378
Accrued liabilities	Accrued liabilities	17,396		29,386			Accrued liabilities	12,739		15,575
Operating lease liabilities, current portion	Operating lease liabilities, current portion	4,148		4,494			Operating lease liabilities, current portion	4,505		4,427
Financing lease liabilities, current portion	Financing lease liabilities, current portion	121		119			Financing lease liabilities, current portion	123		122
Warranty obligations, current portion	Warranty obligations, current portion	3,280		4,968			Warranty obligations, current portion	2,568		2,564
Income taxes payable, current portion	Income taxes payable, current portion	86		839			Income taxes payable, current portion	1,064		328
Debt payable, current portion, net of unamortized debt issuance costs of $476 and $57		1,556		2,243
Debt payable, current portion, net of unamortized debt issuance costs of $422 and $586							Debt payable, current portion, net of unamortized debt issuance costs of $422 and $586	1,807		1,642

Total current liabilities	Total current liabilities	61,553		95,214			Total current liabilities	43,333		54,036
Operating lease liabilities, non-current	Operating lease liabilities, non-current	17,504		20,926			Operating lease liabilities, non-current	15,182		16,380
Financing lease liabilities, non-current	Financing lease liabilities, non-current	311		395			Financing lease liabilities, non-current	254		282
Warranty obligations, non-current	Warranty obligations, non-current	512		1,248			Warranty obligations, non-current	731		703
Income taxes payable, non-current	Income taxes payable, non-current	2,411		4,029			Income taxes payable, non-current	2,014		2,316
Deferred income tax liabilities, non-current	Deferred income tax liabilities, non-current	321		—			Deferred income tax liabilities, non-current	42		253
Other non-current liabilities	Other non-current liabilities	1,374		1,071			Other non-current liabilities	5,469		1,978
Debt payable, non-current, net of unamortized debt issuance costs of $1,349 and $204		58,114		27,113
Debt payable, non-current, net of unamortized debt issuance costs of $986 and $1,513							Debt payable, non-current, net of unamortized debt issuance costs of $986 and $1,513	14,085		26,284
Total liabilities	Total liabilities	142,100		149,996			Total liabilities	81,110		102,232
Commitments and contingencies (Note 17)
Commitments and contingencies (Note 19)							Commitments and contingencies (Note 19)
Shareholders' equity:	Shareholders' equity:						Shareholders' equity:
Common stock - no par value, 75,000 shares authorized, 31,832 and 31,268 shares issued and outstanding		11,046		6,483
Common stock - no par value, 75,000 shares authorized, 35,515 and 31,845 shares issued and outstanding							Common stock - no par value, 75,000 shares authorized, 35,515 and 31,845 shares issued and outstanding	12,384		10,084
Retained earnings	Retained earnings	73,631		158,093			Retained earnings	47,770		52,694

Paid-in-capital							Paid-in-capital	217		—
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(1,684)		(527)			Accumulated other comprehensive loss	(1,300)		(1,478)
Total shareholders' equity	Total shareholders' equity	82,993		164,049			Total shareholders' equity	59,071		61,300
Total liabilities and shareholders' equity	Total liabilities and shareholders' equity	$	225,093	$	314,045		Total liabilities and shareholders' equity	$	140,181	$	163,532

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited and in thousands, except per share amounts)


		Three-Months Ended December 31,				Nine-Months Ended December 31,					Three-Months Ended June 30,
		2022		2021		2022		2021			2023		2022
Net sales	Net sales	$	98,079	$	147,258	$	218,354	$	469,810	Net sales	$	41,750	$	54,817
Cost of sales	Cost of sales	75,219		117,342		177,078		342,336		Cost of sales	33,101		47,860
Gross profit	Gross profit	22,860		29,916		41,276		127,474		Gross profit	8,649		6,957
Operating expenses:	Operating expenses:									Operating expenses:
Selling and marketing	Selling and marketing	17,203		32,395		39,493		75,634		Selling and marketing	6,001		12,891
General and administrative	General and administrative	10,859		11,456		34,317		39,355		General and administrative	8,894		12,463
Research and development	Research and development	5,086		5,379		16,315		15,882		Research and development	3,847		5,823
Restructuring and exit charges										Restructuring and exit charges	440		—
Goodwill and intangible impairment charge	Goodwill and intangible impairment charge	—		—		26,965		—		Goodwill and intangible impairment charge	—		26,965

Total operating expenses	Total operating expenses	33,148		49,230		117,090		130,871		Total operating expenses	19,182		58,142
Operating loss	Operating loss	(10,288)		(19,314)		(75,814)		(3,397)		Operating loss	(10,533)		(51,185)
Other expense:
Other income (expense):										Other income (expense):
Interest income	Interest income	1		1		6		34		Interest income	14		1
Interest expense	Interest expense	(1,187)		(354)		(2,158)		(1,149)		Interest expense	(2,467)		(376)
Other, net	Other, net	715		(789)		(23)		(815)		Other, net	8,567		(514)
Total other expense, net		(471)		(1,142)		(2,175)		(1,930)
Total other income (expense), net										Total other income (expense), net	6,114		(889)
Loss from continuing operations before income taxes	Loss from continuing operations before income taxes	(10,759)		(20,456)		(77,989)		(5,327)		Loss from continuing operations before income taxes	(4,419)		(52,074)
Income tax expense (benefit)		322		(7,001)		8,573		(1,321)
Income tax expense										Income tax expense	505		8,096
Loss from continuing operations	Loss from continuing operations	(11,081)		(13,455)		(86,562)		(4,006)		Loss from continuing operations	(4,924)		(60,170)
Discontinued operations:	Discontinued operations:									Discontinued operations:
Loss from discontinued operations before income taxes		(2)		(118)		(34)		(195)
Income tax (benefit) expense of discontinued operations		(1)		(74)		(2,135)		16
(Loss) income from discontinued operations		(1)		(44)		2,101		(211)

Income tax expense of discontinued operations										Income tax expense of discontinued operations	—		7
Loss from discontinued operations										Loss from discontinued operations	—		(7)
Net loss	Net loss	$	(11,082)	$	(13,499)	$	(84,461)	$	(4,217)	Net loss	$	(4,924)	$	(60,177)

Basic loss per share from continuing operations	Basic loss per share from continuing operations	$	(0.35)	$	(0.43)	$	(2.75)	$	(0.13)	Basic loss per share from continuing operations	$	(0.15)	$	(1.92)
Basic income (loss) per share from discontinued operations		—		—		0.07		(0.01)
Basic loss per share from discontinued operations										Basic loss per share from discontinued operations	—		—
Basic net loss per share	Basic net loss per share	$	(0.35)	$	(0.43)	$	(2.68)	$	(0.14)	Basic net loss per share	$	(0.15)	$	(1.92)

Diluted loss per share from continuing operations	Diluted loss per share from continuing operations	$	(0.35)	$	(0.43)	$	(2.75)	$	(0.13)	Diluted loss per share from continuing operations	$	(0.15)	$	(1.92)
Diluted income (loss) per share from discontinued operations		—		—		0.07		(0.01)
Diluted loss per share from discontinued operations										Diluted loss per share from discontinued operations	—		—
Diluted net loss per share	Diluted net loss per share	$	(0.35)	$	(0.43)	$	(2.68)	$	(0.14)	Diluted net loss per share	$	(0.15)	$	(1.92)

Shares used in per share calculations:	Shares used in per share calculations:									Shares used in per share calculations:
Basic	Basic	31,514		31,199		31,502		30,955		Basic	32,355		31,405
Diluted	Diluted	31,514		31,199		31,502		30,955		Diluted	32,355		31,405

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited and in thousands)

Three-Months Ended December 31, Nine-Months Ended December 31,
2022 2021 2022 2021
Net loss $ (11,082) $ (13,499) $ (84,461) $ (4,217)
Other comprehensive loss:
Unrealized loss on available-for-sale securities, net of income tax expense of $—, $7, $— and $— — — — (4)
Foreign currency translation, net of income tax (expense) benefit of $29, $(2), $(56) and $(10) 923 (148) (1,157) (342)
Other comprehensive income (loss) 923 (148) (1,157) (346)
Comprehensive loss $ (10,159) $ (13,647) $ (85,618) $ (4,563)


	Three-Months Ended June 30,
	2023		2022
Net loss	$	(4,924)	$	(60,177)
Other comprehensive income (loss):


Foreign currency translation, net of income tax (expense) benefit of $8 and $(29)	178		(859)

Comprehensive loss	$	(4,746)	$	(61,036)

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

(Unaudited and in thousands)

Common Stock Retained Earnings Accumulated Other Comprehensive (Loss) Income Total Shareholders' Equity
Shares Amount
Balance, March 31, 2022 31,268 $ 6,483 $ 158,093 $ (527) $ 164,049
Net loss — — (60,177) — (60,177)
Foreign currency translation adjustment,
  net of income tax expense of $29
— — — (859) (859)
Stock-based compensation expense — 1,979 — — 1,979
Common stock issued under equity
  compensation plan, net of shares withheld
  for tax payments 205 (270) — — (270)
Common stock issued under employee stock purchase plan — 125 — — 125
Balance, June 30, 2022 31,473 8,317 97,916 (1,386) 104,847
Net loss — — (13,203) — (13,203)
Foreign currency translation adjustment,
  net of income tax expense of $56
— — — (1,221) (1,221)
Stock-based compensation expense — 1,367 — — 1,367
Common stock issued under equity
  compensation plan, net of shares withheld
  for tax payments 241 (171) — — (171)
Balance, September 30, 2022 31,714 9,513 84,713 (2,607) 91,619
Net loss — — (11,082) — (11,082)
Foreign currency translation adjustment,
  net of income tax benefit of $29
— — — 923 923
Stock-based compensation expense — 1,495 — — 1,495
Common stock issued under equity
  compensation plan, net of shares withheld
  for tax payments 118 (50) — — (50)
Common stock issued under employee stock purchase plan — 88 — — 88
Balance, December 31, 2022 31,832 $ 11,046 $ 73,631 $ (1,684) $ 82,993


	Common Stock					Retained Earnings		Accumulated Other Comprehensive (Loss) Income		Total Shareholders' Equity
	Shares	Amount		APIC









Balance, March 31, 2023	31,845	$	10,084	—		$	52,694	$	(1,478)	$	61,300
Net loss	—	—		—		(4,924)		—		(4,924)


Foreign currency translation adjustment, net of income tax expense of $8	—	—		—		—		178		178
Issuance of common stock and pre-funded warrants, net	3,525	1,335		217		—		—		1,552
Stock-based compensation expense	34	1,050		—		—		—		1,050
Common stock issued under equity compensation plan, net of shares withheld for tax payments	(69)	(85)		—		—		—		(85)
Common stock issued under employee stock purchase plan	180	—		—		—		—		—
Issuance of common stock and pre-funded warrants, net

Balance, June 30, 2023	35,515	$	12,384	$	217	$	47,770	$	(1,300)	$	59,071

~~Table of Contents~~

Common Stock Retained Earnings Accumulated Other Comprehensive (Loss) Income Total Shareholders' Equity
Shares Amount
Balance, March 31, 2021 30,576 $ 2,176 $ 180,524 $ (155) $ 182,545
Net income — — 13,884 — 13,884
Foreign currency translation adjustment,
  net of income tax benefit of $13
— — — 217 217
Stock-based compensation expense — 1,225 — — 1,225
Common stock issued under equity
  compensation plan, net of shares withheld
  for tax payments 201 (1,259) — — (1,259)
Common stock issued under employee stock purchase plan 17 269 — — 269
Balance, June 30, 2021 30,794 2,411 194,408 62 196,881
Net loss — — (4,602) — (4,602)
Unrealized loss on marketable securities, net of income tax expense of $7 — — — (4) (4)
Foreign currency translation adjustment,
  net of income tax expense of $21
— — — (411) (411)
Stock-based compensation expense — 1,540 — — 1,540
Common stock issued under equity
  compensation plan, net of shares withheld
  for tax payments 365 (893) — — (893)
Balance, September 30, 2021 31,159 3,058 189,806 (353) 192,511
Net loss — — (13,499) — (13,499)
Foreign currency translation adjustment,
  net of income tax expense of $2
— — — (148) (148)
Stock-based compensation expense — 1,846 — — 1,846
Common stock issued under equity
  compensation plan, net of shares withheld
  for tax payments 57 (242) — — (242)
Common stock issued under employee stock purchase plan 29 217 — — 217
Balance, December 31, 2021 31,245 $ 4,879 $ 176,307 $ (501) $ 180,685


	Common Stock			Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders' Equity
	Shares	Amount









Balance, March 31, 2022	31,268	$	6,483	$	158,093	$	(527)	$	164,049
Net income	—	—		(60,177)		—		(60,177)


Foreign currency translation adjustment, net of income tax benefit of $29	—	—		—		(859)		(859)
Stock-based compensation expense	—	1,979		—		—		1,979
Common stock issued under equity compensation plan, net of shares withheld for tax payments	205	(270)		—		—		(270)
Common stock issued under employee stock purchase plan	—	125		—		—		125

Balance, June 30, 2022	31,473	$	8,317	$	97,916	$	(1,386)	$	104,847

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited and in thousands)


		Nine-Months Ended December 31,					Three-Months Ended June 30,
		2022		2021			2023		2022
Cash flows from operating activities:	Cash flows from operating activities:					Cash flows from operating activities:
Loss from continuing operations	Loss from continuing operations	$	(86,562)	$	(4,006)	Loss from continuing operations	$	(4,924)	$	(60,170)
Gain (loss) from discontinued operations		2,101		(211)
Loss from discontinued operations						Loss from discontinued operations	—		(7)
Net loss	Net loss	(84,461)		(4,217)		Net loss	(4,924)		(60,177)
Adjustments to reconcile net loss to cash used in operating activities:	Adjustments to reconcile net loss to cash used in operating activities:					Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	Depreciation and amortization	7,956		5,987		Depreciation and amortization	3,150		2,306
Recovery (provision) for allowance for doubtful accounts		549		(468)
Inventory lower of cost or net realizable value		1,196		291
Provision for allowance for doubtful accounts						Provision for allowance for doubtful accounts	60		430
Inventory lower-of-cost-or net realizable value adjustments						Inventory lower-of-cost-or net realizable value adjustments	—		644
Stock-based compensation expense	Stock-based compensation expense	4,830		4,611		Stock-based compensation expense	1,015		1,979
Liability classified stock-based compensation expense		42		—
Gain on asset dispositions	Gain on asset dispositions	(2)		—		Gain on asset dispositions	(9,021)		—
Loss on extinguishment		228		—
Loss on debt extinguishment						Loss on debt extinguishment	352		—
Deferred income taxes, net of valuation allowances	Deferred income taxes, net of valuation allowances	8,200		(2,938)		Deferred income taxes, net of valuation allowances	(182)		8,354
Goodwill and intangible impairment charge	Goodwill and intangible impairment charge	26,965		—		Goodwill and intangible impairment charge	—		26,965
Other	Other	(122)		610		Other	832		(666)

Changes in operating assets and liabilities:	Changes in operating assets and liabilities:					Changes in operating assets and liabilities:
Trade receivables	Trade receivables	18,537		(4,298)		Trade receivables	8,095		33,966
Inventories	Inventories	34,118		(59,258)		Inventories	7,205		8,320
Prepaids and other assets	Prepaids and other assets	5,569		10,059		Prepaids and other assets	2,109		4,012
Income taxes receivable	Income taxes receivable	300		(13,774)		Income taxes receivable	223		282
Trade payables	Trade payables	(16,499)		(36,366)		Trade payables	(8,283)		(25,368)
Liability classified stock-based compensation expense						Liability classified stock-based compensation expense	8		—
Accrued liabilities and other liabilities, including warranty obligations	Accrued liabilities and other liabilities, including warranty obligations	(19,186)		8,178		Accrued liabilities and other liabilities, including warranty obligations	(3,004)		(7,027)
Net cash used in operating activities	Net cash used in operating activities	(11,780)		(91,583)		Net cash used in operating activities	(2,365)		(5,980)
Cash flows from investing activities:	Cash flows from investing activities:					Cash flows from investing activities:
Proceeds from sales and maturities of available-for-sale securities		—		73,448
Acquisition of business, net of cash acquired		—		(26,012)
Proceeds from sale of equity investment						Proceeds from sale of equity investment	2,350		—
Proceeds from sale of intellectual property						Proceeds from sale of intellectual property	10,500		—

Purchases of property, plant and equipment	Purchases of property, plant and equipment	(10,697)		(9,136)		Purchases of property, plant and equipment	(1,178)		(3,381)

Net cash provided by (used in) investing activities	Net cash provided by (used in) investing activities	(10,697)		38,300		Net cash provided by (used in) investing activities	11,672		(3,381)
Cash flows from financing activities:	Cash flows from financing activities:					Cash flows from financing activities:
Proceeds from long-term debt	Proceeds from long-term debt	88,107		63,652		Proceeds from long-term debt	—		17,751
Payments on long-term debt	Payments on long-term debt	(58,064)		(22,477)		Payments on long-term debt	(12,876)		(10,446)

Payment of debt issuance costs		(2,094)		(577)
Payments of debt issuance costs						Payments of debt issuance costs	(762)		—

Early termination of debt						Early termination of debt	(353)		—
Payments on finance lease liabilities	Payments on finance lease liabilities	(90)		(30)		Payments on finance lease liabilities	(30)		(30)
Proceeds from public offering net of transaction costs						Proceeds from public offering net of transaction costs	4,547		—
Proceeds from employee stock purchases	Proceeds from employee stock purchases	213		486		Proceeds from employee stock purchases	35		125
Proceeds from exercise of stock options		—		472

Tax payments related to stock award issuances	Tax payments related to stock award issuances	(480)		(2,866)		Tax payments related to stock award issuances	(85)		(270)

Net cash provided by financing activities		27,592		38,660
Net cash (used in) provided by financing activities						Net cash (used in) provided by financing activities	(9,524)		7,130
Effect of exchange rate changes	Effect of exchange rate changes	(2,847)		(1,529)		Effect of exchange rate changes	185		(3,330)

Net decrease in cash, cash equivalents and restricted cash	Net decrease in cash, cash equivalents and restricted cash	2,268		(16,152)		Net decrease in cash, cash equivalents and restricted cash	(32)		(5,561)

Cash, cash equivalents and restricted cash at beginning of period	Cash, cash equivalents and restricted cash at beginning of period	18,098		39,780		Cash, cash equivalents and restricted cash at beginning of period	18,312		18,098
Cash, cash equivalents and restricted cash at end of period	Cash, cash equivalents and restricted cash at end of period	$	20,366	$	23,628	Cash, cash equivalents and restricted cash at end of period	$	18,280	$	12,537

Supplemental disclosure of cash flow information:	Supplemental disclosure of cash flow information:					Supplemental disclosure of cash flow information:
Cash paid for interest	Cash paid for interest	$	954	$	639	Cash paid for interest	$	734	$	176
Cash paid for income taxes, net		277		19,857
Cash paid (received) for income taxes, net						Cash paid (received) for income taxes, net	23		(514)
Supplemental disclosure of non-cash investing activities:	Supplemental disclosure of non-cash investing activities:					Supplemental disclosure of non-cash investing activities:
Capital expenditures incurred but not yet paid	Capital expenditures incurred but not yet paid	$	368	$	333	Capital expenditures incurred but not yet paid	$	61	$	1,335

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same amounts shown above:	The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same amounts shown above:					The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same amounts shown above:
		Nine-Months Ended December 31,					Three-Months Ended June 30,
		2022		2021			2023		2022
Cash and cash equivalents	Cash and cash equivalents	$	15,532	$	18,402	Cash and cash equivalents	$	17,326	$	7,311
Restricted cash	Restricted cash	947		1,339		Restricted cash	954		1,339
Other current assets - restricted, current	Other current assets - restricted, current	3,887		3,887		Other current assets - restricted, current	—		3,887
Total cash, cash equivalents and restricted cash	Total cash, cash equivalents and restricted cash	$	20,366	$	23,628	Total cash, cash equivalents and restricted cash	$	18,280	$	12,537

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(1) GENERAL INFORMATION

Basis of Consolidation and Presentation

The accompanying condensed consolidated financial statements present the financial position, results of operations and cash flows of Nautilus, Inc. and its subsidiaries, all of which are wholly owned. Intercompany transactions and balances have been eliminated in consolidation.

The accompanying condensed consolidated financial statements have not been audited. We have condensed or omitted certain information and footnote disclosures normally included in financial statements presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes the disclosures contained herein are adequate to make the information presented not misleading. However, these condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, ~~2022~~2023 (the ~~“2022~~“2023 Form 10-K”).

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Uncertainties regarding such estimates and assumptions are inherent in the preparation of financial statements and actual results could differ from those estimates. These uncertainties will be heightened by the COVID-19 pandemic, as we may be unable to accurately predict the impact of COVID-19 going forward and as a result our estimates may change in the near term. Further information regarding significant estimates can be found in our ~~2022~~2023 Form 10-K.

In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments necessary to present fairly our financial position as of ~~December 31, 2022~~June 30, 2023 and March 31, ~~2022,~~2023, and our results of operations, comprehensive loss and shareholders' equity for the ~~three~~three-month period ended June 30, 2023 and ~~nine-month periods ended December 31,~~ 2022 ~~and 2021~~ and our cash flows for the ~~three~~three-month period ended June 30, 2023 and ~~nine-month periods ended December 31, 2022 and 2021.~~2022. Interim results are not necessarily indicative of results for a full year. Our revenues typically vary seasonally, and this seasonality can have a significant effect on operating results, inventory levels and working capital needs.

Unless indicated otherwise, all information regarding our operating results pertain to our continuing operations.

Significant Accounting Policies

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.

Table of Contents

Recent Accounting Pronouncements

Recently Adopted Pronouncements

ASU ~~2020-01~~2016-13

In ~~January 2020,~~June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-01, “Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815).” The amendments in ASU 2020-01 clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815, which could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. These amendments improve current GAAP by reducing diversity in practice and increasing comparability of the accounting for these interactions. ASU 2020-01 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The adoption of ASU 2020-01 in the first quarter of the fiscal year ending March 31, 2023 ("fiscal 2023") did not have any effect on our financial position, results of operations or cash flows.

~~Table of Contents~~

~~ASU 2020-04 and ASU 2021-01~~

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848),” which provides optional guidance related to reference rate reform and provides practical expedients for contract modifications and certain hedging relationships associated with the transition from reference rates that are expected to be discontinued. This guidance is applicable for our borrowing instruments, which use London Inter-bank Offered Rate (“LIBOR”) as a reference rate, which is effective beginning on March 12, 2020, and we may elect to apply the amendments prospectively through December 31, 2022. In January 2021, the FASB issued ASU 2021-01, “Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. The adoption of this guidance had no material impact on our financial position, results of operations or cash flows.

~~Recently Issued Pronouncements Not Yet Adopted~~

~~ASU 2016-13~~

~~In June 2016, the FASB issued ASU~~ 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 requires companies to measure credit losses utilizing a methodology that reflects expected credit losses and requires a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. In May 2019, the FASB issued ASU 2019-05, which provides entities to have certain instruments with an option to irrevocably elect the fair value option. In November 2019,, the FASB issued ASU 2019-11, which provides clarification and addresses specific issues about certain aspects of ASU 2016-13. In March 2020, the FASB issued ASC 2020-03, which provides an update to clarify or address specific issues. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those years. ~~We do not expect the adoption of this guidance would have a~~The Company adopted ASU 2016-13 on April 1, 2023 and it had no material impact on our financial position, results of operations ~~and~~or cash flows.

ASU 2020-06

In August 2020, the FASB issued ASU No. 2020-06, "Debt—Debt with Conversion and Other Options (Subtopic 470-20)" and "Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity," which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. ASU No. 2020-06 will become effective for us on January 1, 2024. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. FASB specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. We early adopted ASU No. 2020-06 on April 1, 2023 and it had no material impact on our financial position, results of operations or cash flows.

(2) DISCONTINUED OPERATIONS

Results from discontinued operations relate to the disposal of our former Nautilus Commercial business, which was completed in April 2011. Although we reached substantial completion of asset liquidation at December 31, 2012, we continued to accrue interest associated with an uncertain tax position on discontinued international operations, and incurred an immaterial amount of product liability expenses associated with products previously sold into the Commercial ~~channel.~~channel through fiscal 2023. Expenses related to discontinued operations were immaterial for the first quarter of fiscal 2024.

(3) RESTRUCTURING AND EXIT CHARGES

In ~~the second quarter of fiscal~~February 2023, we ~~completed~~announced and began implementing a restructuring plan that included a reduction in workforce and other exit costs.

The following table summarizes restructuring reserve activity (in thousands):


	Employee Severance and Benefits		Third Party Costs		Total
Accrued liability as of March 31, 2023	$	1,110	$	123	$	1,233
Charges / Accruals	—		440		440
Payments	(588)		(440)		(1,028)
Accrued liability as of June 30, 2023	$	522	$	123	$	645

The charges incurred due to the ~~tax deregistration of a foreign entity that was part of the discontinued operations. As a result, the previously unrecognized tax benefit~~restructuring plan are included within Restructuring and ~~associated accrued interest and penalty~~exit charges in the ~~amount~~Condensed Consolidated Statements of ~~$2.1 million was released~~Operations and ~~recorded~~the accrued employee severance and benefits as ~~a component~~ of ~~income taxes from discontinued operations during the quarter ended September~~June 30, ~~2022. There were no further significant activities or changes to~~2023 is included in Accrued Liabilities on our ~~discontinued operations during the third quarter of fiscal 2023.~~

Condensed Consolidated Balance Sheets.

Table of Contents

~~(3)~~(4) REVENUES

Our revenues from contracts with customers disaggregated by revenue source, excluding sales-based taxes, were as follows (in thousands):


		Three-Months Ended December 31,				Nine-Months Ended December 31,					Three-Months Ended June 30,
		2022		2021		2022		2021			2023		2022
Product sales	Product sales	$	92,304	$	141,885	$	202,007	$	454,822	Product sales	$	36,771	$	49,596
Extended warranties and services	Extended warranties and services	1,453		1,841		3,433		4,985		Extended warranties and services	750		1,042
Royalty income										Royalty income	427		879
Other(1)	Other(1)	4,322		3,532		12,914		10,003		Other(1)	3,802		3,300
Net sales	Net sales	$	98,079	$	147,258	$	218,354	$	469,810	Net sales	$	41,750	$	54,817

(1) Other revenue is primarily subscription revenue and freight and ~~delivery and royalty income.~~delivery.

Subscriptions

Sales of our subscriptions are deemed to be one performance obligation and we recognize revenue from these arrangements ratably over the subscription term as the performance obligation is satisfied. Revenue generated from subscriptions is recorded in our Direct segment.

We also offer free trials of subscriptions that are bundled with product offerings (e.g., subscription for premium content). For ~~these~~the types of transactions that involve multiple performance obligations, the transaction price requires allocations to the distinct performance obligation because the free trial provides a material right. The transaction price is then allocated to each performance obligation based on stand-alone selling price. We determine stand-alone selling price based on prices charged to customers. Breakage is factored into the determination of the stand-alone selling price of a subscription. Breakage or activation rate is defined as a percentage of those purchasers that never activate a free-trial offering.

Our revenues disaggregated by geographic region, based on ship-to address, were as follows (in thousands):

Three-Months Ended December 31, Nine-Months Ended December 31,
2022 2021 2022 2021
United States $ 75,627 $ 110,870 $ 175,148 $ 360,540
Canada 17,657 22,912 31,852 60,126
Europe, the Middle East and Africa 3,859 9,874 8,038 37,456
All other 936 3,602 3,316 11,688
Net sales $ 98,079 $ 147,258 $ 218,354 $ 469,810

~~Table of Contents~~

As of December 31, 2022, estimated revenue expected to be recognized in the future totaled $18.9 million, primarily related to customer order backlog, which includes firm orders for future shipment and unfulfilled orders to our Retail customers, as well as unfulfilled consumer orders within the Direct channel. Retail orders were $16.8 million and Direct orders were $2.1 million as of December 31, 2022 compared to Retail orders of $44.2 million and Direct orders of $8.8 million as of December 31, 2021. The estimated future revenues are net of contractual rebates and consideration payable for applicable Retail customers, and net of current promotional programs and sales discounts for our Direct customers.


	Three-Months Ended June 30,
	2023		2022
United States	$	32,220	$	46,081
Canada	4,448		5,807
Europe, the Middle East and Africa	4,356		1,839
All other	726		1,090
Net sales	$	41,750	$	54,817

The following table provides information about our liabilities from contracts with customers, primarily customer deposits and deferred revenue for which advance consideration is received prior to the transfer of control or the performance obligation is not satisfied. Revenue is recognized when transfer of control occurs. All customer deposits and deferred revenue received are short-term in nature, recognized over the next twelve months. Significant changes in contract liabilities balances, including revenue recognized in the reporting period that was included in opening contract liabilities, are shown below (in thousands):


		Three-Months Ended December 31,				Nine-Months Ended December 31,					Three-Months Ended June 30,
		2022		2021		2022		2021			2023		2022
Balance, beginning of period	Balance, beginning of period	$	4,194	$	3,453	$	6,285	$	5,551	Balance, beginning of period	$	5,075	$	6,285
Cash additions	Cash additions	3,315		4,203		6,112		8,749		Cash additions	387		1,549
Deferred Revenue										Deferred Revenue	978		982
Revenue recognition	Revenue recognition	(2,361)		(1,378)		(7,249)		(8,022)		Revenue recognition	(2,008)		(2,234)
Balance, end of period	Balance, end of period	$	5,148	$	6,278	$	5,148	$	6,278	Balance, end of period	$	4,432	$	6,582

~~(4)~~

Table of Contents

(5) FAIR VALUE MEASUREMENTS

Factors used in determining the fair value of financial assets and liabilities are summarized into three broad categories:

•Level 1 - observable inputs such as quoted prices (unadjusted) in active liquid markets for identical securities as of the reporting date;

•Level 2 - other significant directly or indirectly observable inputs, including quoted prices for similar securities, interest rates, prepayment speeds and credit risk, or observable market prices in markets with insufficient volume and/or infrequent transactions; and

•Level 3 - significant inputs that are generally unobservable inputs for which there is little or no market data available, including our own assumptions in determining fair value.

~~Assets and liabilities~~We did not have any assets measured at fair value on a recurring basis as of June 30, 2023 or March 31, 2023. Liabilities measured at fair value on a recurring basis were as follows (in thousands):


	December 31, 2022
	Level 1		Level 2		Level 3		Total
Assets:

										June 30, 2023
										Level 1		Level 2		Level 3		Total

Derivatives

Foreign currency forward contracts	$	—	$	239	$	—	$	239

Total assets measured at fair value	$	—	$	239	$	—	$	239

Liabilities:									Liabilities:
Common Warrants									Common Warrants	$	—	$	—	$	2,994	$	2,994
Derivatives									Derivatives

Foreign currency forward contracts									Foreign currency forward contracts	—		141		—		141
Total liabilities measured at fair value									Total liabilities measured at fair value	$	—	$	141	$	2,994	$	3,135


		March 31, 2022									March 31, 2023
		Level 1		Level 2		Level 3		Total			Level 1		Level 2		Level 3		Total
Liabilities:	Liabilities:									Liabilities:
Derivatives	Derivatives									Derivatives

Foreign currency forward contracts	Foreign currency forward contracts	$	—	$	128	$	—	$	128	Foreign currency forward contracts	$	—	$	141	$	—	$	141
Total liabilities measured at fair value	Total liabilities measured at fair value	$	—	$	128	$	—	$	128	Total liabilities measured at fair value	$	—	$	141	$	—	$	141

~~Table of Contents~~

For our assets measured at fair value on a recurring basis, we recognize transfers between levels at the actual date of the event or change in circumstance that caused the transfer. There were no transfers between levels during the nine-month period ended December 31, 2022, nor for the fiscal year ended March 31, 2022 ("fiscal 2022"). Additionally, weWe did not have any changes to our valuation techniques during ~~either of these periods.~~any periods presented.

The fair ~~values~~value of our foreign currency forward contracts ~~are~~is calculated as the present value of estimated future cash flows using discount factors derived from relevant Level 2 market inputs, including forward curves and volatility levels.

The carrying value of our debt approximates its fair value and falls under Level 2 of the fair value hierarchy, as the interest rate is variable and based on current market rates.

~~During the nine-month period ended December 31, 2022, we evaluated~~The Company determined the fair value of ~~our goodwill~~the Common Warrant liability using the price of the Public Warrants as a Level 3 input.

Inherent in a Black Scholes valuation model are assumptions related to expected stock price, exercise price, stock-price volatility derived using the Company’s historical volatility, expected term, risk-free interest rate and ~~intangible assets because triggering events~~dividend yield. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected term of the Common Warrants. The dividend yield percentage is zero based on the Company's current expectations related to the payment of dividends during the expected term of the Common Warrants.

Table of Contents

The key inputs into the Black Scholes pricing model were ~~identified. See Note 8~~as follows:

~~for additional information.~~


			June 30, 2023
Stock Price			$1.22
Exercise Price			$1.35
Expected Life			5.47
Expected Volatility			63.05%
Expected Dividend Yield			—%
Risk Free Rate			4.05%

~~(5)~~(6) DERIVATIVES

From time to time, we enter into interest rate swaps to fix a portion of our interest expense, and foreign exchange forward contracts to offset the earnings impacts of exchange rate fluctuations on certain monetary assets and liabilities. We do not enter into derivative instruments for any purpose other than to manage interest rate or foreign currency exposure. That is, we do not engage in interest rate or currency exchange rate speculation using derivative instruments.

We may hedge our net recognized foreign currency assets and liabilities with forward foreign exchange contracts to reduce the risk that our earnings and cash flows will be adversely affected by changes in foreign currency exchange rates. These derivative instruments hedge assets and liabilities that are denominated in foreign currencies and are carried at fair value with changes in the fair value recorded as other income. These derivative instruments do not subject us to material balance sheet risk due to exchange rate movements because gains and losses on these derivatives are intended to offset gains and losses on the assets and liabilities being hedged. As of ~~December 31, 2022,~~June 30, 2023, total outstanding contract notional amounts were ~~$13.8~~$7.2 million and had maturities of 76126 days or less.

The fair value of our derivative instruments was included in our ~~condensed consolidated balance sheets~~Condensed Consolidated Balance Sheets as follows (in thousands):

~~Balance Sheet Classification~~

~~As of~~

~~December 31, 2022~~

~~March 31, 2022~~

~~Derivative instruments not designated as cash flow hedges:~~

~~Foreign currency forward contracts~~

~~Prepaids and other current assets~~

~~239~~

—

~~Foreign currency forward contracts~~

~~Accrued liabilities~~

—

~~128~~

Balance Sheet Classification

As of

June 30, 2023

March 31, 2023

Derivative instruments not designated as cash flow hedges:

Foreign currency forward contracts

Accrued liabilities

141

The effect of derivative instruments on our ~~condensed consolidated statements~~Condensed Consolidated Statements of ~~operations~~Operations was as follows (in thousands):

Statement of Operations Classification Three-months ended December 31, Nine-Months Ended December 31,
2022 2021 2022 2021
Derivative instruments not designated as cash flow hedges:
Income (loss) recognized in earnings Other, net $ 993 $ 797 $ 404 $ (163)
Income tax expense (benefit) Income tax expense (benefit) 249 (194) 101 40


	Statement of Operations Classification	Three-months ended June 30,
		2023		2022





Derivative instruments not designated as cash flow hedges:
Loss recognized in earnings	Other, net	$	—	$	(96)
Income tax expense	Income tax expense	—		(24)

~~Table of Contents~~

~~(6)~~(7) INVENTORIES

Inventories are stated at the lower of cost and net realizable value, with cost determined based on the first-in, first-out method. Our inventories consisted of the following (in thousands):

As of
December 31, 2022 March 31, 2022
Finished goods $ 72,421 $ 104,988
Parts and components 4,894 6,202
Total inventories $ 77,315 $ 111,190

Table of Contents


	As of
	June 30, 2023		March 31, 2023
Finished goods	$	35,921	$	42,463
Parts and components	3,870		4,136
Total inventories	$	39,791	$	46,599

~~(7)~~(8) PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consisted of the following (in thousands):


		Estimated Useful Life (in years)				As of							Estimated Useful Life (in years)								As of
					December 31, 2022			March 31, 2022				Estimated Useful Life (in years)									June 30, 2023			March 31, 2023
Automobiles	Automobiles		5					$	23					$	23						Automobiles		5			$	23			$	23
Leasehold improvements	Leasehold improvements	4	to	20		3,597				3,150						Leasehold improvements		4		to		20			3,446				3,426
Computer software and equipment	Computer software and equipment	2	to	7		46,752				44,852					Computer software and equipment		2		to		7			57,213				57,223
Machinery and equipment	Machinery and equipment	3	to	5		15,037				16,447					Machinery and equipment		3		to		5			14,953				14,953
Furniture and fixtures	Furniture and fixtures	5	to	20		2,047				2,634					Furniture and fixtures		5		to		20			2,034				2,034
Work in progress(1)	Work in progress(1)	N/A				13,009				6,678					Work in progress(1)		N/A							4,944				4,061
Total cost	Total cost					80,465				73,784					Total cost									82,613				81,720
Accumulated depreciation	Accumulated depreciation					(46,321)				(41,655)					Accumulated depreciation									(52,111)				(48,931)
Total property, plant and equipment, net	Total property, plant and equipment, net					$	34,144			$	32,129				Total property, plant and equipment, net									$	30,502			$	32,789

(1) Work in progress includes information technology assets and production tooling.

Depreciation expense was as follows (in thousands):

Three-Months Ended December 31, Nine-Months Ended December 31,
2022 2021 2022 2021
Depreciation expense $ 3,155 $ 1,993 $ 7,910 $ 5,941


	Three-Months Ended June 30,
	2023		2022
Depreciation expense	$	3,135	$	2,291

~~(8)~~(9) GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

~~The roll forward of goodwill was as follows (in thousands):~~

~~Total~~

~~Balance, March 31, 2022~~

~~24,510~~

~~Goodwill impairment~~

~~(24,510)~~

~~Balance, December 31, 2022~~

—

~~In accordance with ASC 350 — Intangibles —~~ ~~Goodwill and Other,~~ ~~we perform our goodwill and indefinite-lived trade names~~We did not have any impairment valuations annually, on March 31, or sooner if triggering events are identified. While the fair value of our reporting units exceeded their respective carrying values as of March 31, 2022, we observed continued market volatility including significant declines in our market capitalization during the three-month period ended June 30, 2022, identified as a triggering event. Our trailing 30-day average market capitalization was approximately $137 million at March 31, 2022 compared to $66 million, the trailing 30-day average, as of June 30, 2022. We performed an interim evaluation and a market capitalization reconciliationcharges during the first quarter of fiscal ~~2023, which resulted in a non-cash~~2024, nor did we have any goodwill ~~impairment charge of $24.5 million.~~

~~We assigned assets and liabilities to each reporting unit based~~ on ~~either specific identification or by using judgment for the remaining assets and liabilities that are not specific to a reporting unit. We determined the fair value of our~~

~~Table of Contents~~

reporting units in Step 1 of the ASC 350 analysis using the market approach. In addition, we determined the fair value by adding a control premium observed from recent transactions of comparable companies to determine the reasonableness of that assumption and the fair values of the reporting units estimated in Step 1. Significant unobservable inputs and assumptions inherent in the valuation methodologies from Level 3 inputs were employed and include, but were not limited to, prospective financial information, growth rates, terminal value, royalty rates, discount rates, and comparable multiples from publicly traded companies in our industry. We compared the carrying amount of each reporting unit to its respective fair value. We reconciled the aggregate fair values of the reporting units determined in Step 1 (as described above) to the enterprise market capitalization plus a reasonable control premium. This total value was compared to a trailing 30-day average market capitalization of approximately $66 million as ofCondensed Consolidated Balance Sheets at June 30, 2022. As a result, the market capitalization reconciliation analysis identified that the Direct reporting unit's fair value was significantly lower than its carrying value, resulting in a non-cash goodwill impairment charge of $24.5 million.2023 or March 31, 2023.

Other Intangible Assets

Other intangible assets consisted of the following (in thousands):


		Estimated Useful Life (in years)				As of							Estimated Useful Life (in years)						As of
					December 31, 2022			March 31, 2022				Estimated Useful Life (in years)							June 30, 2023			March 31, 2023
Indefinite-lived trademarks (1)	Indefinite-lived trademarks (1)		N/A					$	6,597					$	9,052				Indefinite-lived trademarks (1)		N/A			$	2,900			$	6,597

Patents	Patents	7	to	24		1,043				1,043						Patents	7	to		24			1,044				1,043

						7,640				10,095												3,944				7,640
Accumulated amortization - definite-lived intangible assets	Accumulated amortization - definite-lived intangible assets					(838)				(791)					Accumulated amortization - definite-lived intangible assets							(869)				(853)
Other intangible assets, net	Other intangible assets, net					$	6,802			$	9,304				Other intangible assets, net							$	3,075			$	6,787

(1) During the first quarter of fiscal 2023, we identified impairment indicators with our indefinite-lived trademarks resulting in a $2.5 million non-cash intangible impairment charge.

Table of Contents

During the quarter ended June 30, 2023, we completed the sale of indefinite-lived intellectual property for $10.5 million as part of our ongoing comprehensive strategic review. The sale of these assets, which included the Nautilus brand trademark assets and related licenses, will continue to streamline our brand focus and enhance our financial flexibility. The carrying value of the intangible assets sold was $3.7 million and the resulting gain, net of transaction costs, was recorded in Other Income.

Amortization expense was as follows (in thousands):

Three-Months Ended December 31, Nine-Months Ended December 31,
2022 2021 2022 2021
Amortization expense $ 15 $ 15 $ 46 $ 46


	Three-Months Ended June 30,
	2023		2022
Amortization expense	$	15	$	15

Future amortization of definite-lived intangible assets is as follows (in thousands):


Remainder of fiscal 2023		$	15
2024		61
Remainder of fiscal 2024				Remainder of fiscal 2024	$	46
2025	2025	61		2025	61
2026	2026	47		2026	47
2027	2027	3		2027	3
2028				2028	3
Thereafter	Thereafter	18		Thereafter	15
		$	205		$	175

~~(9)~~(10) THE SALE OF SHARES IN EQUITY INVESTMENTS

On May 1, 2023, the Company completed the sale of Vi Labs for $2.3 million as part of its ongoing comprehensive strategic review. The sale of this equity investment will continue to streamline the Company’s brand focus and enhance its financial flexibility. The carrying value of the assets sold was $0.0 million and transaction costs of the sale was $0.1 million. The resulting gain of $2.2 million, net of transaction costs, will be recorded in the Condensed Consolidated Statements of Operations as Other income and in the Condensed Consolidated Statements of Cash Flows as Proceeds from sale of equity investment for the quarter ended June 30, 2023.

(11) LEASES

We have several non-cancellable operating leases, primarily for office space, that expire at various dates over the next seven years. These leases generally contain renewal options to extend for one lease term of five years. For leases that we are reasonably certain we will exercise the lease renewal options, the options were considered in determining the lease term, and associated potential option payments are included in the lease payments. The payments used in the renewal term were estimated using the percentage rate increase of historical rent payments for each location where the renewal will be exercised.

Payments due under the lease contracts include annual fixed payments for office space. Variable payments including payments for our proportionate share of the building’s property taxes, insurance, and common area maintenance are treated as non-lease components and are recognized in the period for which the costs occur.

~~Table of Contents~~

Lease expense was as follows (in thousands):


		Three-Months Ended December 31,				Nine-Months Ended December 31,					Three-Months Ended June 30,
		2022		2021		2022		2021			2023		2022
Operating lease expense	Operating lease expense	$	1,406	$	1,465	$	4,466	$	4,397	Operating lease expense	$	1,334	$	1,533
Amortization of finance lease assets	Amortization of finance lease assets	28		29		85		29		Amortization of finance lease assets	28		28

Total lease expense	Total lease expense	$	1,434	$	1,494	$	4,551	$	4,426	Total lease expense	$	1,362	$	1,561

Leases with an initial term of 12 months or less (“short-term leases”) are not recorded on the balance sheet and are recognized on a straight-line basis over the lease term.

Table of Contents

Other information related to leases was as follows (dollars in thousands):

As of
December 31, 2022 March 31, 2022
Supplemental cash flow information related to leases was as follows:
Operating leases:
Operating lease right-of-use-assets $ 20,033 $ 23,620
Operating lease liabilities, non-current $ 17,504 $ 20,926
Operating lease liabilities, current portion 4,148 4,494
Total operating lease liabilities $ 21,652 $ 25,420
Finance leases:
Property, plant and equipment, at cost $ 512 $ 569
Accumulated depreciation (86) (57)
Property, plant and equipment, net $ 426 $ 512
Finance lease obligations, non-current $ 311 $ 395
Finance lease obligations, current portion 121 119
Total finance lease liabilities $ 432 $ 514
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flow from operating leases $ 4,996 $ 6,485
Finance cash flows from finance leases 90 60
Additional lease information:
ROU assets obtained in exchange for operating lease obligations $ — $ 10,323
ROU assets obtained in exchange for finance lease obligations — 569
Reductions to ROU assets resulting from reductions to operating lease obligations 901 1,358
Weighted Average Remaining Lease Term:
Operating leases 2.4 years 3.1 years
Finance leases 3.8 years 4.5 years
Weighted Average Discount Rate:
Operating leases 4.65% 4.65%
Finance leases 2.14% 2.14%


	As of
	June 30, 2023		March 31, 2023
Supplemental cash flow information related to leases was as follows:

Operating leases:
Operating lease right-of-use-assets	$	18,009	$	19,078

Operating lease liabilities, non-current	$	15,182	$	16,380
Operating lease liabilities, current portion	4,505		4,427
Total operating lease liabilities	$	19,687	$	20,807

Finance leases:
Property, plant and equipment, at cost	$	569	$	569
Accumulated depreciation	(199)		(171)
Property, plant and equipment, net	$	370	$	398

Finance lease obligations, non-current	$	254	$	282
Finance lease obligations, current portion	123		122
Total finance lease liabilities	$	377	$	404

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flow from operating leases	$	1,594	$	6,226
Finance cash flows from finance leases	30		119

Additional lease information:
ROU assets obtained in exchange for operating lease obligations	$	—	$	100
ROU assets obtained in exchange for finance lease obligations	—		—
Reductions to ROU assets resulting from reductions to operating lease obligations	260		1,175


Weighted Average Remaining Lease Term:
Operating leases	4.8 years		5.0 years
Finance leases	3.3 years		3.5 years

Weighted Average Discount Rate:
Operating leases	5.05%		5.05%
Finance leases	2.08%		2.08%

~~Table of Contents~~

We determined the discount rate for leases using a portfolio approach to determine an incremental borrowing rate to calculate the right-of-use assets and lease liabilities.

Maturities of lease liabilities under non-cancellable leases were as follows (in thousands):

As of December 31, 2022
Operating leases Finance leases
Remainder of fiscal 2023 $ 1,011 $ 29
2024 5,532 120
2025 5,599 120
2026 4,517 120
2027 2,359 60
Thereafter 5,796 —
Total undiscounted lease payments 24,814 449
Less imputed interest (3,162) (17)
Total lease liabilities $ 21,652 $ 432

Table of Contents



	As of June 30, 2023
	Operating leases		Finance leases
Remainder of fiscal 2024	$	3,992	$	90
2025	5,650		120
2026	4,525		120
2027	2,365		60

Thereafter	5,796		—
Total undiscounted lease payments	22,328		390
Less imputed interest	(2,641)		(13)
Total lease liabilities	$	19,687	$	377

~~(10)~~(12) CAPITAL STOCK

Issuance of Common Stock

On June 15, 2023, the Company entered into a securities purchase agreement (“Securities Purchase Agreement”) with a certain institutional investor (“Purchaser”). Pursuant to the Securities Purchase Agreement, the Company agreed to sell in a registered direct offering (“Registered Direct Offering”) 3,525,000 shares (“Shares”) of the Company’s common stock, no par value (“Common Stock”), and purchase contracts issued as pre-funded warrants (“Pre-Funded Warrants”) to purchase up to 573,362 shares of Common Stock, which Pre-Funded Warrants are issued to the extent that the Purchaser determines, in its sole discretion, that such Purchaser would beneficially own in excess of 4.99% (or at the Purchaser’s election, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities. The Pre-Funded Warrants have an exercise price of $0.0001 per share and are immediately exercisable and can be exercised at any time after their original issuance date until such Pre-Funded Warrants are exercised in full. Each Share was sold at an offering price of $1.22 and each Pre-Funded Warrant was sold at an offering price of $1.2199 (equal to the purchase price per Share minus the exercise price of the Pre-Funded Warrant). As of June 30, 2023, the Pre-Funded Warrants were not exercised.

Pursuant to the Securities Purchase Agreement, in a concurrent private placement (together with the Registered Direct Offering, the "Offerings"), we also issued to the Purchaser unregistered warrants (“Common Warrants”) to purchase up to 4,098,362 shares of our common stock. Each Common Warrant has an exercise price of $1.35 per share, is exercisable at any time beginning six months following their original issuance date and will expire five and a half years from the original issuance date. As of June 30, 2023, the Common Warrants were not exercised.

In the event of any Fundamental Transaction, including any merger or consolidation, sale of assets, tender or exchange offer for 50% or more of outstanding common stock, reclassification, reorganization or recapitalization of our shares of common stock, or purchase of more than 50% or more of our outstanding shares of common stock, then upon any subsequent exercise of a Common Warrant, the holder will have the right to receive as alternative consideration, for each share of common stock that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, the number of shares of common stock of the successor or acquiring corporation of our company, if it is the surviving corporation, and any additional consideration receivable upon or as a result of such transaction by a holder of the number of shares of common stock for which the Common Warrant is exercisable immediately prior to such event. Notwithstanding the foregoing, in the event of a Fundamental Transaction, the holders of the Common Warrants have the right to require us or a successor entity to redeem the Common Warrants for cash in the amount of the Black Scholes Value (as defined in each Common Warrant) of the unexercised portion of the Common Warrants concurrently with or within 30 days following the consummation of a fundamental transaction.

The Company accounts for its Common Warrants in accordance with the guidance contained in ASC 815-40, Derivatives and Hedging - Contracts on an Entity’s Own Equity, and determined that the Common Warrants do not meet the criteria for equity treatment thereunder. As such, each Common Warrant must be recorded as a liability and is subject to re-measurement at each balance sheet date. Refer to Note 5 - Fair Value Measurements for further details. Changes in fair value are recognized in change in fair value of warrant liability in the Company’s condensed consolidated statements of operations.

Table of Contents

Roth Capital Partners, LLC (the “Placement Agent”) acted as the exclusive placement agent for the Offerings, pursuant to a Placement Agency Agreement, dated June 15, 2023, by and between the Company and the Placement Agent (the “Placement Agreement”).

Pursuant to the Placement Agreement, we have agreed to pay the Placement Agent a cash placement fee equal to 7.0% of the aggregate gross proceeds raised in the Offerings from sales arranged for by the Placement Agent. Subject to certain conditions, we also have agreed to reimburse all reasonable travel and other out-of-pocket expenses of the Placement Agent in connection with the Offerings, including but not limited to legal fees, up to a maximum of $75,000. The Placement Agreement contains customary representations, warranties and agreements by us and customary conditions to closing. We have agreed to indemnify the Placement Agent against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”), and liabilities arising from breaches of representations and warranties contained in the Placement Agreement, or to contribute to payments that the Placement Agent may be required to make in respect of those liabilities.

We received net proceeds of $4.6 million from the Offerings, net of offering expenses paid to the Placement Agent totaling $0.4 million, which proceeds will be used for general corporate purposes.

The closing of the Offerings took place on June 20, 2023. The Securities were offered and sold pursuant to our shelf registration statement on Form S-3 (File No. 333-249979) initially filed with the Securities and Exchange Commission (the “Commission”) on November 9, 2020 and declared effective on October 28, 2021. A prospectus supplement relating to the Registered Direct Offering was filed with the Commission on June 15, 2023. None of the Common Warrants or the shares of Common Stock issuable upon the exercise of the Common Warrants are registered under the Securities Act. The Common Warrants and shares of Common Stock issuable upon exercise thereof will be issued in reliance on the exemptions from registration provided by Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder for transactions not involving a public offering.

(13) ACCRUED LIABILITIES

Accrued liabilities consisted of the following (in thousands):


		As of				As of
		December 31, 2022		March 31, 2022				June 30, 2023		March 31, 2023

Payroll and related liabilities	Payroll and related liabilities	$	7,570	$	10,405		Payroll and related liabilities	$	3,744	$	5,220
Deferred revenue	Deferred revenue	5,148		6,285			Deferred revenue	4,432		5,075
Legal settlement (2)		33		4,250
Reserves (1)							Reserves (1)	960		1,200
Accrued Tariffs							Accrued Tariffs	1,224		1,167

Other	Other	2,930		4,013			Other	2,379		2,913
Reserves (1)		1,715		4,433
Total accrued liabilities	Total accrued liabilities	$	17,396	$	29,386		Total accrued liabilities	$	12,739	$	15,575

(1) Reserves primarily consists of inventory, sales return, sales tax and product liability reserves.

~~(2)~~ Legal settlement is a loss contingency accrual related to a legal settlement involving a class action lawsuit related to advertisement of our treadmills. For further information, see Note 17, Commitments and Contingencies.

~~(11)~~(14) PRODUCT WARRANTIES

Our products carry defined warranties for defects in materials or workmanship which, according to their terms, generally obligate us to pay the costs of supplying and shipping replacement parts to customers and, in certain instances, pay for labor and other costs to service products. Outstanding product warranty periods range from thirty days to, in limited circumstances, the lifetime of certain product components. We record a liability at the time of sale for the estimated costs of fulfilling future warranty claims. If necessary, we adjust the liability for specific warranty-related matters when they become known and are reasonably estimable. Estimated warranty expense is included in cost of sales, based on historical warranty claim experience and available product quality data. Warranty expense is affected by the performance of new products, significant manufacturing or design defects not discovered until after the product is delivered to the customer, product failure rates, and higher or lower than expected repair costs. If warranty expense differs from previous estimates, or if circumstances change such that the assumptions inherent in previous estimates are no longer valid, the amount of product warranty obligations is adjusted accordingly.

Table of Contents

Changes in our product warranty obligations were as follows (in thousands):


		Nine-Months Ended December 31,					Three-Months Ended June 30,
		2022		2021			2023		2022
Balance, beginning of period	Balance, beginning of period	$	4,351	$	8,651	Balance, beginning of period	$	3,267	$	6,216
Accruals	Accruals	1,030		4,416		Accruals	1,404		844

Payments	Payments	(1,589)		(5,942)		Payments	(1,372)		(2,064)
Balance, end of period	Balance, end of period	$	3,792	$	7,125	Balance, end of period	$	3,299	$	4,996

~~(12)~~(15) ACCUMULATED OTHER COMPREHENSIVE LOSS

The following tables set forth the changes in accumulated other comprehensive loss, net of tax (in thousands):

Foreign Currency Translation Adjustments Accumulated Other Comprehensive Loss
Balance, March 31, 2022 $ (527) $ (527)
Current period other comprehensive loss before reclassifications (1,157) (1,157)
Net other comprehensive loss during period (1,157) (1,157)
Balance, December 31, 2022 $ (1,684) $ (1,684)


	Foreign Currency Translation Adjustments		Accumulated Other Comprehensive Loss
Balance, March 31, 2023	$	(1,478)	$	(1,478)
Current period other comprehensive income before reclassifications	178		178


Balance, June 30, 2023	$	(1,300)	$	(1,300)

Foreign Currency Translation Adjustments Accumulated Other Comprehensive (Loss) Income
Balance, September 30, 2022 $ (2,607) $ (2,607)
Current period other comprehensive loss before reclassifications 923 923
Net other comprehensive loss during period 923 923
Balance, December 31, 2022 $ (1,684) $ (1,684)



	Foreign Currency Translation Adjustments		Accumulated Other Comprehensive Loss
Balance, March 31, 2022	$	(527)	$	(527)
Current period other comprehensive income before reclassifications	(859)		(859)


Balance, June 30, 2022	$	(1,386)	$	(1,386)

Unrealized Loss on Available-for-Sale Securities Foreign Currency Translation Adjustments Accumulated Other Comprehensive Loss
Balance, March 31, 2021 $ (8) $ (147) $ (155)
Current period other comprehensive income before reclassifications (4) (342) (346)
Net other comprehensive income during period (4) (342) (346)
Balance, December 31, 2021 $ (12) $ (489) $ (501)

~~Table of Contents~~

Unrealized Loss on Available-for-Sale Securities Foreign Currency Translation Adjustments Accumulated Other Comprehensive Loss
Balance, September 30, 2021 $ (12) $ (341) $ (353)
Current period other comprehensive income before reclassifications — (148) (148)
Net other comprehensive income during period — (148) (148)
Balance, December 31, 2021 $ (12) $ (489) $ (501)

~~(13)~~(16) LOSS PER SHARE

Basic per share amounts were computed using the weighted average number of common shares outstanding. Diluted per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method. Basic income per share amounts were computed using the weighted average number of common shares outstanding. Diluted income per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method.

The weighted average numbers of shares outstanding used to compute (loss) income per share were as follows (in thousands):

Three-Months Ended December 31, Nine-Months Ended December 31,
2022 2021 2022 2021
Shares used to calculate basic income per share 31,514 31,199 31,502 30,955
Dilutive effect of outstanding stock options, performance stock units and restricted stock units — — — —
Shares used to calculate diluted income per share 31,514 31,199 31,502 30,955


	Three-Months Ended June 30,
		2023	2022
Shares used to calculate basic income per share		32,355	31,405
Dilutive effect of outstanding stock options, performance stock units and restricted stock units		—	—
Shares used to calculate diluted income per share		32,355	31,405

Potentially Dilutive Shares

Table of Contents

The weighted average ~~numbers~~number of potentially dilutive shares outstanding listed in the table below were ~~dilutive and are~~ excluded from the computation of diluted per share ~~due when there is~~amounts since we had a loss from continuing operations in both periods, as such, the exercise or conversion of any ~~potential~~potentially dilutive shares would increase the number of shares in the denominator and ~~results~~result in a lower ~~income (loss)~~loss per diluted share.

~~These~~

The weighted average number of potentially dilutive shares ~~may be dilutive potential common shares in the future~~outstanding were as follows (in thousands):

Three-Months Ended December 31, Nine-Months Ended December 31,
2022 2021 2022 2021
Restricted stock units 102 673 201 1,024
Stock options 44 357 104 504
Total potential dilutive shares excluded due to net loss 146 1,030 305 1,528


	Three-Months Ended June 30,
	2023	2022

Stock options	—	156
RSUs	48	296
PSUs	—	24
Total potentially dilutive shares excluded due to net loss	48	476

~~Anti-dilutive~~Anti-Dilutive Shares

The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted ~~income (loss)~~loss per share. In the case of restricted stock units, this is because unrecognized compensation expense exceeds the current value of the awards (i.e., grant date market value was higher than current average market price). In the case of stock options, this is because the average market price did not exceed the exercise price.

These shares may be anti-dilutive potential common shares in the future (in thousands):

~~Table of Contents~~


		Three-Months Ended December 31,		Nine-Months Ended December 31,			Three-Months Ended June 30,
		2022	2021	2022	2021		2023	2022

Restricted stock units						Restricted stock units	944	1,576
Stock options	Stock options	1,849	1,168	1,391	333	Stock options	1,805	2
RSUs		855	2	193	2
Total anti-dilutive shares excluded	Total anti-dilutive shares excluded	2,704	1,170	1,584	335	Total anti-dilutive shares excluded	2,749	1,578

~~(14)~~(17) SEGMENT AND ENTERPRISE-WIDE INFORMATION

We have two operating segments, Direct and Retail. There were no changes in our operating segments during the ~~nine-months~~three-months ended ~~December 31, 2022.~~June 30, 2023.

We evaluate performance of the operating segments using several factors, of which the primary financial measures are net sales and reportable segment contribution. Contribution is the measure of profit or loss, defined as net sales less product costs and directly attributable expenses. Directly attributable expenses include selling and marketing expenses, general and administrative expenses, and research and development expenses that are directly related to segment operations. Segment assets are those directly assigned to an operating segment's operations, primarily accounts receivable, inventories, goodwill and other intangible assets. Unallocated assets primarily include cash, cash equivalents and restricted cash, derivative securities, shared information technology infrastructure, distribution centers, corporate headquarters, prepaids and other current assets, deferred income tax assets and other assets. Capital expenditures directly attributable to the Direct and Retail segments were not significant in any period.

1817

Table of Contents

Following is summary information by reportable segment (in thousands):


		Three-Months Ended December 31,				Nine-Months Ended December 31,					Three-Months Ended June 30,
		2022		2021		2022		2021			2023		2022
Net sales:	Net sales:									Net sales:
Direct	Direct	$	46,729	$	60,705	$	97,686	$	161,954	Direct	$	21,846	$	26,476
Retail	Retail	50,601		85,701		117,949		305,338		Retail	19,477		27,444
Royalty	Royalty	749		852		2,719		2,518		Royalty	427		897
Consolidated net sales	Consolidated net sales	$	98,079	$	147,258	$	218,354	$	469,810	Consolidated net sales	$	41,750	$	54,817

Contribution:	Contribution:									Contribution:
Direct	Direct	$	(6,463)	$	(8,980)	$	(24,244)	$	(4,056)	Direct	$	(4,708)	$	(9,893)
Retail	Retail	3,447		3,270		(994)		44,101		Retail	382		(5,408)
Royalty	Royalty	749		852		2,719		2,518		Royalty	427		897
Consolidated contribution	Consolidated contribution	$	(2,267)	$	(4,858)	$	(22,519)	$	42,563	Consolidated contribution	$	(3,899)	$	(14,404)

Reconciliation of consolidated contribution to (loss) income from continuing operations:
Reconciliation of consolidated contribution to loss from continuing operations:										Reconciliation of consolidated contribution to loss from continuing operations:
Consolidated contribution	Consolidated contribution	$	(2,267)	$	(4,858)	$	(22,519)	$	42,563	Consolidated contribution	$	(3,899)	$	(14,404)
Amounts not directly related to segments:	Amounts not directly related to segments:									Amounts not directly related to segments:
Operating expenses(1)	Operating expenses(1)	(8,021)		(14,456)		(53,295)		(45,960)		Operating expenses(1)	(6,634)		(36,781)
Other expense, net	Other expense, net	(471)		(1,142)		(2,175)		(1,930)		Other expense, net	6,114		(889)
Income tax expense	Income tax expense	(322)		7,001		(8,573)		1,321		Income tax expense	(505)		(8,096)
Loss from continuing operations	Loss from continuing operations	$	(11,081)	$	(13,455)	$	(86,562)	$	(4,006)	Loss from continuing operations	$	(4,924)	$	(60,170)
(1) Included in unallocated Operating expenses is 25.4 million of Goodwill and intangible impairment charge related to the Direct segment and 1.6 million of intangible impairment charge related to the Retail segment that is not included in the contribution performance measured by the chief operating decision maker.
(1) Included in unallocated Operating expenses for the three months ended June 30, 2022 is $25.4 million of Goodwill and intangible impairment charge related to the Direct segment and $1.6 million of intangible impairment charge related to the Retail segment that is not included in the contribution performance measured by the chief operating decision maker.										(1) Included in unallocated Operating expenses for the three months ended June 30, 2022 is $25.4 million of Goodwill and intangible impairment charge related to the Direct segment and $1.6 million of intangible impairment charge related to the Retail segment that is not included in the contribution performance measured by the chief operating decision maker.


		As of				As of
		December 31, 2022		March 31, 2022				June 30, 2023		March 31, 2023
Assets:	Assets:						Assets:
Direct	Direct	$	62,953	$	93,554		Direct	$	43,164	$	50,493
Retail	Retail	97,385		144,683			Retail	39,367		58,214
Unallocated corporate	Unallocated corporate	64,755		75,808			Unallocated corporate	57,650		54,825
Total assets	Total assets	$	225,093	$	314,045		Total assets	$	140,181	$	163,532

The following ~~customers~~customer accounted for 10% or more of total net sales as follows:

Three-Months Ended December 31, Nine-Months Ended December 31,
2022 2021 2022 2021
Amazon.com 10.0% * 22.0% 14.4%
Best Buy * 14.0% * 16.6%
Costco 11.0% * * *
*Less than 10% of total net sales.


	Three-Months Ended June 30,
	2023	2022
Amazon.com	11.2%	29.4%

~~Table of Contents~~

~~(15)~~(17) BORROWINGS

~~SLR Credit Agreement~~Entry into Amended Term Loan Facility

On ~~November 30, 2022,~~April 25, 2023, we entered into a an amendment (the “Term Loan ~~Credit Agreement (the “SLR Credit Agreement”~~Amendment”) to our existing Term Loan with Crystal Financial LLC, ~~D/B/A~~d/b/a SLR Credit Solutions ~~a Delaware limited liability company,~~("SLR") dated as ~~administrative agent (“SLR”) and lenders from time to time party thereto (collectively~~of November 30, 2022 (as amended, the ~~“Lenders”~~"SLR Term Loan").

Pursuant to the SLR Credit Agreement, the Lenders have agreed, among other things, to make available to us a term loan facility in the aggregate principal amount of up to $30.0 million, subject to a borrowing base (the “SLRThe Term Loan Facility”), as such amounts may increase or decrease in accordance with the terms of the SLR Credit Agreement. The principal amount of the loan will initially bear interest based on the Adjusted Term SOFR rate plus a margin of 8.25%. From and after the 2024 Financial Statement Delivery Date, the margin will be either 7.75% or 8.25% based on whether our fixed charge coverage ratio is greater than 1.00 to 1.00 or less than or equal to 1.00 to 1.00, respectively.

Borrowings under the SLR Credit Agreement will mature, and all outstanding amounts thereunder will be payable on October 29, 2026, unless the maturity is accelerated subject to the terms set forth in the SLR Credit Agreement or if there is an earlier maturity of the Wells Fargo Credit Agreement (as defined below). The obligations of each Borrower under the SLR Credit Agreement are secured by a lien on substantially all of our assets.

The SLR Credit Agreement contains customary affirmative and negative covenants for financings of this type, including, among other terms and conditions, delivery of financial statements, reports and maintenance of corporate existence, availability subject to a calculated borrowing base, as well as limitations and conditions on our ability to: create, incur, assume or be liable for indebtedness; dispose of assets outside the ordinary course; acquire, merge or consolidate with or into another person or entity; create, incur or allow any lien on any of our property; make investments; or pay dividends or make distributions, in each case subject to certain exceptions. The financial covenants set forth in the SLR Credit Agreement initially requireAmendment permits us to (a) maintain minimum excess availability of at least the greater of (i) $10.0 million (subject to increase set forth in the SLR Credit Agreement related to utilization of any incremental term loan facilities thereunder) or (ii) 12.5% of the sum of (x) the line cap under the Wells Fargo Credit Agreement (calculated without giving effect to any term pushdown reserve) plus (y) the lesser of (A) the outstanding principal balance of the loans under the SLR Credit Agreemententer into certain asset disposition transactions (the “Specified Transactions”) and ~~(B) the borrowing base under the SLR Credit Agreement~~a license amendment transaction (the “Combined Line Cap”). From and after the date on which both the fixed charge coverage ratio for the previous 12-month period is at least 1.00 to 1.00 and availability under the Wells Fargo Credit Agreement is equal to or greater than $20.0 million, we shall no longer be subject to a minimum excess availability covenant but rather would be required to maintain a fixed charge coverage ratio of at least 1.00:1.00 tested when availability under the Wells Fargo Credit Agreement is less than the greater of (i) 12.5% of the Combined Line Cap (excluding the effect, if any, of any term pushdown reserve), and (ii) $11.0 million, calculated as of the last day of each fiscal quarter (the “Financial Covenants”“License Amendment Transaction”). In addition, the SLR Credit Agreement includes customary events of default, including but not limited to, the nonpayment of principal and interest when due thereunder, breaches of representations and warranties, noncompliance with covenants, acts of insolvency and default on indebtedness held by third parties (subject to certain limitations and cure periods).

connection

This description of the SLR Credit Agreement is a summary only and qualified in its entirety by reference to the text of the SLR Credit Agreement, which is included in the exhibit index of this Form 10-Q for the period ending December 31, 2022.

~~Amendment to Existing WF ABL Revolving Facility~~

On November 30, 2022, the Company also entered into an Amendment (the “Amendment”) by and among the Company, as borrower, Wells Fargo Bank, National Assocation as Agent, and the lenders from time to time party thereto (the "WF Lenders"), which amended the Company’s existing asset-based revolving loan facility (the "WF ABL Revolving Facility") and term loan facility (the "WF Term Loan Facility" and together with the WF ABL Revolving Facility, the "WF Credit Facility"), dated as of January 31, 2020, among the Company, the lenders from time to time party thereto and Wells Fargo, as Agent (the “Existing Credit Agreement” and, as amended by the Amendment, the “Wells Fargo Credit Agreement”). Capitalized terms used but not defined in this report have the meanings ascribed to such terms in the Wells Fargo Credit Agreement.

The Amendment terminated the term loans thereunder in connection with the refinancing described above and permitted the entry into and the lien and guarantees related to the SLR Credit Agreement. The guarantees and liens

2018

Table of Contents

therewith, the minimum excess availability covenant will step-down from the greater of: $10.0 million and 12.5% of the Combined Line Cap, to the greater of: (a) $9.0 million and 12.5% of the Combined Line Cap after the consummation of the first Specified Transaction and (b) $7.0 million and 12.5% of the Combined Line Cap after the consummation of each subsequent Specified Transaction. We prepaid $11.8 million of principal outstanding on the Term Loan with the cash proceeds received from the consummation of the Specified Transactions and the License Amendment Transaction.

Amendment to Existing ABL Credit Agreement

On April 25, 2023, we entered into an amendment (the “ABL Amendment”) to our existing inCredit Agreement with Wells Fargo Bank, National Association ("Wells Fargo") dated as of January 31, 2020 (as amended, the “ABL Credit Facility Agreement”) with Wells Fargo Bank, National Association (“Wells Fargo”). The ABL Amendment permits us to enter into the Specified Transactions and the License Amendment Transaction, subject to satisfaction of the terms and conditions set forth therein. In connection therewith, the minimum excess availability covenant will step-down from the greater of: $10.0 million and 12.5% of the Combined Line Cap, to the greater of: (a) $9.0 million and 12.5% of the Combined Line Cap after the consummation of the first Specified Transaction and (b) $7.0 million and 12.5% of the Combined Line Cap after the consummation of each subsequent Specified Transaction. In addition, the ABL Amendment reduced the maximum revolving loan commitment amount from $100 million to $60 million.

In connection with the ~~Wells Fargo Credit Agreement remained in place upon the closing~~amendment of the transaction contemplated by the SLR Credit Agreement with respect to the revolving asset-based loans under the Wells Fargo Credit Agreement. The Wells Fargo Credit Agreement was also amended to add Financial Covenants consistent with the SLR Credit Agreement. The principal amounteach of the loans continue to bear interest based on the base rate or the SOFR rate, plus an applicable margin. The Amendment increased the margin applicable to SOFR loans and letters of credit to a range of 5.00% to 5.50% from a range of 1.75% to 2.25% in the Existing Credit Agreement (based on the maximum revolver amount) and the margin applicable to base rate loans to a range of 4.00% to 4.50% from a range of 0.75% to 1.25% in the Existing Credit Agreement (based on the maximum revolver amount). Borrowings under the Wells Fargo Credit Agreement are scheduled to mature, and all outstanding amounts thereunder will be payable on October 29, 2026, unless the maturity is accelerated subject to the terms set forth in the Wells Fargo Credit Agreement or if there is an earlier maturity of the SLR Credit Agreement.

Other than as specifically provided in the Amendment, the Amendment had no effect on any schedules, exhibits or attachments to the Existing Credit Agreement. Other than as specifically provided in the Amendment, the Guaranty and Security Agreement related to the Wells Fargo Credit Agreement remains in effect.

This description of the Amendment is a summary only and qualified in its entirety by reference to the text of the Amendment and the Wells Fargo Credit Agreement, which are included in the exhibit index of this Form 10-Q for the period ending December 31, 2022.

~~We used the proceeds from~~ the SLR Term Loan ~~Facility to extinguish our existing $9.1 million WF Term Loan Facility, to pay transaction expenses,~~ and ~~for general corporate purposes. In connection with the extinguishment of the WF Fargo Term Loan~~ABL Credit Facility, we recorded a loss of ~~$0.2~~$0.9 million and $0.6 million, respectively, as a component of Other, net in our Condensed Consolidated Statements of Operations.

As of ~~December 31, 2022,~~June 30, 2023, outstanding principal and accrued and unpaid interest totaled ~~$61.5~~$17.3 million, with ~~$30.3~~$17.1 million and ~~$31.2~~$0.2 million under our SLR Term Loan ~~Facility~~ and ~~WF Revolver,~~ABL Credit Facility, respectively. As of ~~December 31, 2022,~~June 30, 2023, we were in compliance with the financial covenants ofcontained in the agreements governing both the SLR Term Loan and ABL Credit ~~Agreement~~Facility, and ~~WF Credit Agreement, and $26.9~~$9.5 million was available for borrowing under WF ABL ~~Revolving~~Credit Facility.

As of June 30, 2023, our interest rate was 10.28% for the ABL Credit Facility and 13.79% for the SLR Term Loan. Interest on the ~~WF Revolver loan facility~~ABL Credit Facility accrues at the Secured Overnight Financing Rate ("SOFR") plus a margin of 5.00% to 5.50% (based on average quarterly availability) and interest on the SLR Term Loan Facility accrues at SOFR plus a margin of 7.75% to 8.25% (based on fixed charge coverage ratio). ~~As of December 31, 2022, our interest rate was 9.40% for the WF Revolver and 12.92% for the SLR Term Loan Facility.~~

The balance sheet classification of the borrowings under the ~~revolving~~ loan ~~facility~~facilities has been determined in accordance with ASC 470, Debt.

~~(16) INCOME TAXES~~

~~Valuation Allowance~~

~~Under ASC Topic 740,~~ ~~Accounting for Income Taxes~~, we must periodically evaluate deferred tax assets to determine if it is more-likely-than-not that the future tax benefits will be realized. If the negative evidence outweighs the positive, a valuation allowance must be recognized to reduce the net carrying amount of the deferred tax assets to the amount more-likely-than-not to be realized.

Evaluating the need for, and amount of, a valuation allowance for deferred tax assets often requires significant judgment and extensive analysis of all available evidence on a jurisdiction-by-jurisdiction basis. Such judgments require us to interpret existing tax law and other published guidance as applied to our circumstances. As part of this assessment, we consider both positive and negative evidence. The weight given to the potential effect of positive and negative evidence must be commensurate with the extent to which the strength of the evidence can be objectively verified. We generally consider the following, but are not limited to, objectively verified evidence to determine the likelihood of realization of the deferred tax assets:

•Our current financial position and our historical results of operations for recent years. We generally consider cumulative pre-tax losses in the three-year period ending with the current quarter or a projected three-year cumulative loss position within the next 12 months following the current quarter to be significant negative evidence.

•~~A pattern of objectively-measured historical and current financial reporting loss trend is heavily weighted as a source of negative evidence.~~

~~Table of Contents~~

•Sources of taxable income of the appropriate character. Future realization of deferred tax assets is dependent on projected taxable income of the appropriate character. Future reversals of existing temporary differences are heavily weighted sources of objectively verifiable evidence. Projections of future taxable income exclusive of reversing temporary differences are a source of positive evidence only when the projections are combined with a history of recent profits and current financial trends and can be reasonably estimated.

•~~Carry-back and carry-forward periods available. The carry-back and carry-forward periods permitted under the tax law are objectively verified evidence.~~

•Tax planning strategies. Tax planning strategies can be, depending on their nature, heavily-weighted sources of objectively verifiable positive evidence when the strategies are available and can be reasonably executed. We consider tax planning strategies only if they are feasible and justifiable considering our current operations and our strategic plan. Tax planning strategies, if executed, may accelerate the recovery of a deferred tax asset so the tax benefit of the deferred tax asset can be carried back.

Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. In the first quarter of fiscal 2023, a significant new piece of objective negative evidence evaluated was the third year of cumulative losses projected within the next twelve months. Such objective evidence limits our ability to consider other subjective evidence, such as our projections for future growth.

Based on this evaluation in the first quarter of fiscal 2023, Management concluded that it was no longer more likely than not that the tax benefits from the existing U.S deferred tax assets would be realized. Management sustains the same position in the current quarter and, therefore, we continue to recognize a valuation allowance to reduce our U.S deferred tax assets to an anticipated realizable value. We recognized a $2.8 million and a $20.6 million valuation allowance in the three and nine-months ended December 31, 2022, respectively, against our domestic uncovered net deferred tax assets.

~~(17)~~(19) COMMITMENTS AND CONTINGENCIES

Operating leases

We lease property and equipment under non-cancellable operating leases which, in the aggregate, extend through 2029. Many of these leases contain renewal options and provide for rent escalations and payment of real estate taxes, maintenance, insurance and certain other operating expenses of the properties.

For additional information related to leases, see see Note 911 Leases.

Guarantees, Commitments and Off-Balance Sheet Arrangements

As of ~~December 31, 2022,~~June 30, 2023, we had standby letters of credit of $1.6 million.

We have long lead times for inventory purchases and, therefore, must secure factory capacity from our vendors in advance. As of ~~December 31, 2022,~~June 30, 2023, we had approximately ~~$9.3~~$33.0 million, compared to ~~$39.8~~$12.1 million as of March 31, ~~2022,~~2023, in non-cancellable market-based purchase obligations, primarily to secure additional factory capacity for inventory purchases in the next twelve months. ~~The decrease in purchase obligations was primarily due to having received much of the inventory we have ordered for the season.~~ Purchase obligations can vary from quarter-to-quarter and versus the same period in prior years due to a number of factors, including the amount of products that are shipped directly to Retail customer warehouses versus through Nautilus warehouses.

Table of Contents

indemnify them against claims arising from their use or sale of our products; real estate and equipment leases, under which we may indemnify lessors against third-party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.

The nature and terms of these indemnification obligations vary from contract to contract, and generally a maximum obligation is not stated within the agreements. We hold insurance policies that mitigate potential losses arising from certain types of indemnification obligations. Management does not deem these obligations to be significant to our

~~Table of Contents~~

financial position, results of operations or cash flows, and therefore, no related liabilities were recorded as of ~~December 31, 2022.~~June 30, 2023.

Legal Matters

From time to time, in the ordinary course of business, we may be involved in various claims, lawsuits and other proceedings. These legal and tax proceedings involve uncertainty as to the eventual outcomes and losses which may be realized when one or more future events occur or fail to occur.

We regularly monitor our estimated exposure to these contingencies and, as additional information becomes known, may change our estimates accordingly. We evaluate, on a quarterly basis, developments in legal proceedings, investigations or claims that could affect the amount of any accrual, as well as any developments that would make a loss probable or reasonably possible, and whether the amount of a probable or reasonably possible loss is estimable. Among other factors, we evaluate the advice of internal and external counsel, the outcomes from similar litigation, the current status of the lawsuits (including settlement initiatives), legislative developments and other factors. Due to the numerous variables associated with these judgments and assumptions, both the precision and reliability of the resulting estimates of the related loss contingencies are subject to substantial uncertainties. Further, while we face contingencies that are reasonably possible to occur, ~~other than as discussed below,~~ we are unable to estimate the possible loss or range of loss at this time.

During the second quarter of fiscal 2022, we recorded a $4.7 million loss contingency related to a legal settlement involving a class action lawsuit related to advertisement of our treadmills. The settlement included damages, a one-year free membership to ~~JRNY~~®, and administrative fees and was included as a component of General and administrative on our Condensed Consolidated Statements of Operations. We paid the settlement damages and related administrative fees during the second fiscal quarter of fiscal 2023.

~~(18)~~(20) SUBSEQUENT EVENTS

~~Cost Reduction Initiatives~~Amendment to Existing Term Loan Credit Agreement

~~In February~~On July 28, 2023, we ~~executed a reduction~~entered into an amendment (the “Second Term Loan Amendment”) to our existing SLR Term Loan with SLR as amended on April 25, 2023. Capitalized terms used but not defined in ~~our workforce by approximately 15%. In addition, we~~this section of this report have ~~reduced our contracted labor, leveraging~~ the ~~flexibility of our variable operating model.~~meanings ascribed to such terms in the SLR Term Loan.

~~We expect~~The Second Term Loan Amendment will provide us with a greater borrowing advance rate for certain eligible accounts owing by Amazon.com, Inc. and its affiliates and allow for certain reports to ~~incur restructuring and other one-time charges of approximately $3.0 million~~be delivered monthly (rather than weekly) so long as specified conditions are satisfied.Other than as specifically provided in the ~~Q4 Fiscal~~Term Loan Amendment, the Second Term Loan Amendment had no effect on any schedules, exhibits or attachments to the Term Loan Credit Agreement.Other than as specifically provided in the Second Term Loan Amendment, the Guaranty and Security Agreements related to the Term Loan Credit Agreement remain in effect.

This description of the Second Term Loan Amendment is a summary only and qualified in its entirety by reference to the text of the Term Loan Amendment, which is filed as Exhibit 10.3.

Amendment to Existing ABL Credit Agreement

On July 28, 2023, we entered into an amendment (the “Second ABL Amendment”) to ~~Q1 Fiscal 2024 time frame.~~our existing ABL Credit Facility Agreement with Wells Fargo as amended on April 25, 2023. Capitalized terms used but not defined in this section of this report have the meanings ascribed to such terms in the ABL Credit Facility Agreement.

The Second ABL Amendment will provide us with a greater borrowing advance rate for certain eligible accounts owing by Amazon.com, Inc. and its affiliates and allow for certain reports to be delivered monthly (rather than weekly) so long as specified conditions are satisfied.Other than as specifically provided in the ABL Amendment, the Second ABL Amendment had no effect on any schedules, exhibits or attachments to the ABL Credit Facility

2320

Table of Contents

Agreement.In addition, the Second ABL Amendment will reduce the maximum revolving loan commitment amount from $60.0 million to $40.0 million.

Other than as specifically provided in the ABL Amendment, the Second ABL Amendment had no effect on any schedules, exhibits or attachments to the ABL Credit Facility Agreement.Other than as specifically provided in the Second ABL Amendment, the Guaranty and Security Agreement related to the ABL Credit Facility Agreement remains in effect.

This description of the Second ABL Amendment is a summary only and qualified in its entirety by reference to the text of the ABL Amendment, which is filed as Exhibit 10.4.

Issuance of Common Stock

As described in Note12, Capital Stock, on June 15, 2023, the Company entered into a Securities Purchase Agreement to sell in a Registered Direct Offering 3,525,000 shares of the Company’s common stock and purchase contracts issued as “Pre-Funded Warrants” to purchase up to 573,362 shares of Common Stock. The closing of the Offering took place on June 20, 2023. On July 28, 2023, 573,362 shares of Common Stock were exercised.

Table of Contents

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis is based upon our financial statements as of the dates and for the periods presented in this section. You should read this discussion and analysis in conjunction with the financial statements and notes thereto found in Part I, Item 1 of this Form 10-Q and our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, ~~2022~~2023 (the ~~“2022~~“2023 Form 10-K”). All references to the ~~third~~first quarters and ~~nine-months~~three-months ended of fiscal ~~2023~~2024 and fiscal ~~2022~~2023 mean for the ~~three~~three-month period ended June 30, 2023 and ~~nine-month periods ended December 31,~~ 2022, ~~and 2021,~~ respectively. Unless the context otherwise requires, “Nautilus,” “we,” “us” and “our” refer to Nautilus, Inc. and its subsidiaries. Unless indicated otherwise, all information regarding our operating results pertains to our continuing operations.

Cautionary Notice About Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “plan,” “expect,” “aim,” “believe,” “project,” “intend,” “estimate,” “will,” “should,” “could,” and other terms of similar meaning typically identify forward-looking statements. We also may make forward-looking statements in our other documents filed with or furnished to the U.S. Securities and Exchange Commission (the “SEC”). In addition, our senior management may make forward-looking statements orally to analysts, investors, representatives of the media and others. Forward-looking statements include any statements related to our future business, financial performance or operating results; anticipated fluctuations in net sales due to seasonality; plans and expectations regarding gross and operating margins; plans and expectations regarding research and development expenses and capital expenditures and anticipated results from such expenditures and other investments in our capabilities and resources; anticipated losses from discontinued operations; plans for new product introductions, strategic partnerships and anticipated demand for our new and existing products; and statements regarding our inventory and working capital requirements and the sufficiency of our financial resources. These forward-looking statements, and others we make from time-to-time, are subject to a number of risks and uncertainties. Many factors could cause actual results to differ materially from those projected in forward-looking statements, including our ability to timely acquire inventory that meets our quality control standards from sole source foreign manufacturers at acceptable costs, changes in consumer fitness trends, changes in the media consumption habits of our target consumers or the effectiveness, availability and price of media time consistent with our cost and audience profile parameters, greater than anticipated costs or delays associated with launch of new products, weaker than expected demand for new or existing products, a decline in consumer spending due to unfavorable economic conditions, softness in the retail marketplace or the availability from retailers of heavily discounted competitive products, an adverse change in the availability of credit for our customers who finance their purchases, our ability to pass along vendor raw material price increases and other cost pressures, including increased shipping costs and unfavorable foreign currency exchange rates, tariffs, risks associated with current and potential delays, work stoppages, or supply chain disruptions caused by the coronavirus pandemic, our ability to hire and retain key management personnel, our ability to effectively develop, market and sell future products, the availability and timing of capital for financing our strategic initiatives, including being able to raise capital on favorable terms or at all; changes in the financial markets, including changes in credit markets and interest rates that affect our ability to access those markets on favorable terms, the impact of any future impairments, our ability to protect our intellectual property, the introduction of competing products, and our ability to get foreign-sourced product through customs in a timely manner. Additional assumptions, risks and uncertainties are described in Part I, Item 1A, “Risk Factors,” in our ~~2022~~2023 Form 10-K as supplemented or modified in our quarterly reports on Form 10-Q. We do not undertake any duty to update forward-looking statements after the date they are made or conform them to actual results or to changes in circumstances or expectations.

Overview

We empower healthier living through individualized connected fitness experiences and are committed to building a healthier world, one person at a time. Our principal business activities include designing, developing, sourcing and marketing high-quality cardio and strength fitness products, related accessories and a digital platform for consumer use, primarily in the U.S., Canada, Europe and Asia. Our products are sold under some of the most-recognized brand names in the fitness industry: ~~Bowflex~~BowFlex®, Schwinn®, JRNY®and previously the Nautilus®.brand. Consistent with our North Star strategy, in fiscal 2023 we sold the Nautilus brand trademark assets and related licenses, which we view as non-core assets.

We market our products through two distinct distribution channels, Direct and Retail, which we consider to be separate business segments. Our Direct business offers products directly to consumers primarily through

Table of Contents

websites. Our Retail business offers our products through a network of independent retail companies to reach consumers in the home use markets in the U.S. and internationally. We also derive a portion of our revenue from the licensing of our brands and intellectual property.

~~Table of Contents~~

Our results for the ~~three and nine-months~~three-months ended ~~December 31, 2022, are~~June 30, 2023 were driven by the actions outlined in our North Star strategy. The five strategic pillars of our North Star strategy are: (1) ~~Adopt~~adopt a consumer first mindset; (2) ~~Scale~~scale a differentiated digital offering; (3) ~~Focus~~focus investments on core businesses; (4) ~~Evolve~~evolve supply chain to be a strategic advantage; and (5) ~~Build~~build organizational capabilities to win by unleashing the power of our team. We ~~intend to leverage our many strengths to transform into~~have made strong progress on all these pillars over the past two years and we believe that we have set the foundation for becoming a ~~company that empowers healthier living through individualized~~leader in connected fitness ~~experiences.~~ by leveraging our equipment business and scaling a differentiated offering.

Our transformation will ~~properly leverage~~build on our leading brands, products, innovation, distribution and digital ~~assets~~assets. Our operating model is a strategic advantage. Our asset-light manufacturing, diversified product portfolio, omni-channel distribution and variable cost structure, which enables tight management of margin, operating expenses and inventory levels, is a model built to flex with variability in market conditions.

The profound and enduring shift in consumer fitness habits post-pandemic toward at-home workouts continues to enhance the long-term opportunity for the Company. This is a long-term shift and the Company is well-positioned to take advantage of this opportunity.

To weather the macro-economic and retail challenges that we currently face, we are staying grounded in our mission and unwavering dedication to build a healthier world, one person at a time.

~~On September 26, 2022, we announced the launch~~ We also remain steadfast in our strategy to provide consumers a broad variety of superior products at a range of price points via our ~~comprehensive review of strategic alternatives~~omni-channel distribution model. We continue to ~~identify opportunities to accelerate~~enhance our ~~digital transformation under~~product portfolio with our ~~previously announced North Star plan and enhance shareholder value. That process continues, but we have not set a timetable for the conclusion of the process and there can be no assurance~~differentiated JRNY® connected fitness offering. We believe that the ~~review will result in any transaction or other strategic change.~~

~~At the center~~advantages associated with a broad assortment of ~~health~~products and well-being is fitness. The market size more than doubled over the past 2 years, is regulating from its peak with more normal seasonality, and we expect will settle at a “new normal” above pre-pandemic levels (but below the pandemic peak) based on an ongoing evolution in consumers’ workouts and workplace habits. As a result of these changed habits and sentiments, we continue to believe in the industry’s growth opportunities. This results in stronger opportunity for our industry and Nautilus.

Despite solid demand in our Direct segment, headwinds in our Retail segment persist as our retail partners continue to take heavily conservative inventory positions in light of uncertainty in the economic environment. In response, we have taken strategic actions to reduce our costs and realign our business, allowingomni-channel distribution model allow us to ~~mitigate these near-term challenges, enhance cash flow and drive long-term profitable growth.~~

~~To gauge sales growth against more "normalized," pre-pandemic results, we will rely more heavily on measuring performance~~offset areas of ~~fiscal 2023 versus the pre-pandemic twelve-month period ended March 31, 2020 ("fiscal 2020") rather than measuring performance against the atypical, outsized results that occurred during the pandemic~~.weakness.

Comparison for the Three-Months Ended ~~December 31, 2022~~June 30, 2023 to the Three-Months Ended ~~December 31, 2021~~June 30, 2022

•Net sales were ~~$98.1~~$41.8 million, compared to ~~$147.3~~$54.8 million, a decline of ~~33.4%~~23.8% versus last year. ~~Net sales are up 9%, when compared to the same period in fiscal 2020, excluding sales related to the Octane brand, which was sold in October 2020.~~ The sales decline versus last year iswas driven primarily by ~~the return to pre-pandemic seasonal~~lower customer demand.

•Net sales of our Direct segment decreased by ~~$14.0~~$4.6 million, or ~~23.0%~~17.5%, for the three-months ended ~~December 31, 2022,~~June 30, 2023, compared to the three-months ended ~~December 31, 2021. Net sales were up 30.2% compared to the same period in fiscal 2020.~~June 30, 2022. The net sales decrease compared to last year was primarily driven by ~~the return to pre-pandemic seasonal demand and pre-pandemic sales discounting practices.~~lower customer demand.

•Net sales of our Retail segment decreased by ~~$35.1~~$8.0 million, or ~~41.0%~~29.0%, for the three-months ended ~~December 31, 2022,~~June 30, 2023, compared to the three-months ended ~~December 31, 2021. Net sales were down 6%, compared to the same period in fiscal 2020, excluding sales related to the Octane brand, which was sold in 2020. The~~June 30, 2022.The decrease in sales compared to last year was primarily driven by ~~the return to pre-pandemic seasonal demand.~~lower demand as retailers work through higher-than-normal inventory levels.

•Royalty income for the three-months ended ~~December 31, 2022~~June 30, 2023 decreased by ~~$0.1~~$0.5 million compared to the three-months ended ~~December 31, 2021.~~June 30, 2022. The decrease was primarily due to decreased royalty income as a result of the sale of the Nautilus brand trademarks and related royalty licenses.

•Gross profit was ~~$22.9~~$8.6 million, compared to ~~$29.9~~$7.0 million last year, an increase of 24.3% versus last year. Gross profit margins were ~~23.3%~~20.7% compared to ~~20.3%~~12.7% last year. The ~~3.0~~8.0 ppt increase in gross margins was primarily due to ~~decreases in inventory adjustments (+3 ppts),~~ lower landed product costs (+11 ppts), decreased discounting (+2 ppts), ~~partially~~favorable logistics overhead absorption (+1 ppt), offset by unfavorable ~~logistics overhead~~ absorption ~~(-1 ppt)~~of JRNY COGS (-5 ppts), and ~~higher~~increased outbound freight (-1 ~~ppt)~~ppts). ~~JRNY~~® ~~investments were lower in dollars versus the prior year and negatively affected gross margins by only 0.40 ppts.~~

•Operating expenses were ~~$33.1~~$19.2 million compared to ~~$49.2~~$58.1 million last year. The decrease of ~~$16.1~~$39.0 million, or ~~32.7%~~67.0%, was primarily ~~driven by $12.7~~due to $27.0 million asset impairment charge in fiscal 2023, $4.3 million decrease in personnel expenses, $4.0 million lower media spending, ~~a decrease of~~ $2.1 million ~~due to~~

~~Table of Contents~~

~~other cost savings, and a~~decrease in contracted services, $1.3 million decrease in other costs, and $0.7 million in other variable selling, and marketing expenses due to decreased ~~sales.~~sales, offset by $0.4 million increase in restructuring related charges. Total advertising expenses were ~~$9.5~~$1.1 million this year versus ~~$22.3~~$5.1 million last year.

Table of Contents

•Operating loss was ~~$10.3~~$10.5 million compared to an operating loss of ~~$19.3~~$51.2 million last year, primarily driven by ~~improved gross margins and~~ lower operating ~~expenses.~~expenses and higher gross profit.

•Income tax ~~expense was $0.3~~expenses were $0.5 million this year compared to ~~a $7.0~~$8.1 million last year. Expenses this quarter are primarily driven by foreign related taxes and FIN 48 reserves related to an income tax audit. No tax benefit associated with domestic losses was recognized due to the U.S. deferred tax asset valuation allowance position established last year. ~~The income~~Income tax expense ~~this quarter~~for the three-months ended June 30, 2022 was primarily ~~related to activities in foreign jurisdictions, as well as~~a result of the ~~recording of a $2.8 million~~U.S. deferred tax asset valuation allowance.

•Loss from continuing operations was ~~$11.1~~$4.9 million, or ~~$0.35~~$0.15 per diluted share, compared to a loss of ~~$13.5~~$60.2 million, or ~~$0.43~~$1.92 per diluted share, last year.

•Net loss was ~~$11.1~~$4.9 million, or ~~$0.35~~$0.15 per diluted share, compared to net loss of ~~$13.5~~$60.2 million or ~~$0.43~~$1.92 per diluted share, last year.

~~Comparison for the Nine-Months Ended December 31, 2022 to the Nine-Months Ended December 31, 2021~~

•Net sales were $218.4 million, compared to $469.8 million, a decline of 53.5% versus last year. Net sales are up 13% when compared to the same period in fiscal 2020, excluding sales related to the Octane brand, which was sold in October 2020. The sales decline versus last year is driven primarily by the return to pre-pandemic seasonal demand and pre-pandemic sales discounting practices, as our typical sales discounts were largely unnecessary during the pandemic period.

•Net sales of our Direct segment decreased by $64.3 million, or 39.7%, for the nine-months ended December 31, 2022, compared to the nine-months ended December 31, 2021. Net sales were up 33.9% compared to the same period in fiscal 2020. The net sales decrease compared to last year is primarily driven by the return to pre-pandemic seasonal demand and pre-pandemic sales discounting practices.

•Net sales of our Retail segment decreased by $187.4 million, or 61.4%, for the nine-months ended December 31, 2022, compared to the nine-months ended December 31, 2021. Net sales were flat, compared to the same period in fiscal 2020, excluding sales related to the Octane brand, which was sold in 2020. The net sales decrease compared to last year is primarily driven by lower cardio sales and higher sales discounting.

•~~Royalty income for the nine-months ended December 31, 2022 increased by $0.2 million compared to the nine-months ended December 31, 2021.~~

•Gross profit was $41.3 million, compared to $127.5 million last year. Gross profit margins were 18.9% compared to 27.1% last year. The 8.2 ppt decrease in gross margins was primarily due to increased discounting (-5 ppts), unfavorable logistics overhead absorption (-4 ppts), increased investments in JRNY® ~~(-2 ppts), and higher outbound freight (-1 ppt), partially offset by a decrease in product costs (+4 ppts).~~

•Operating expenses were $117.1 million compared to $130.9 million last year. The decrease of $13.8 million, or 10.5%, was primarily due to a $28.0 million decrease in media spending, a $6.6 million decrease in other variable selling and marketing expenses due to decreased sales, a decrease of $6.5 million due to savings in other operating expenses, and a $4.7 million prior year loss contingency for a legal settlement, partially offset by a goodwill and intangible impairment charge of $27.0 million and a $5.0 million increase in JRNY® ~~investments. Total advertising expenses were $18.3 million versus $46.3 million last year.~~

•Operating loss was $75.8 million or a negative 34.7% operating margin, compared to an operating loss of $3.4 million last year, primarily driven by a goodwill and intangible impairment charge of $27.0 million and lower gross profit associated with lower sales demand during the period.

•Income tax expense was $8.6 million this year compared to a $1.3 million tax benefit last year. The income tax expense in the current year was primarily the result of the $20.6 million U.S. deferred tax asset valuation allowance.

~~Table of Contents~~

•~~Loss from continuing operations was $86.6 million, or $2.75 per diluted share, compared to a loss of $4.0 million, or $0.13 per diluted share, last year.~~

•~~Net loss was $84.5 million, or $2.68 per diluted share, compared to a loss of $4.2 million or $0.14 per diluted share, last year.~~

North Star Strategy Update

JRNY® Digital Platform

•Nautilus continues to enhance ~~the JRNY~~® ~~platform through many unique~~and refine existing JRNY® features that are popular with customers, including ~~the expansion of~~its personalized recommendations and differentiated, ~~visual connected-fitness experiences for JRNY~~® ~~Members.~~adaptive workouts.

•As of ~~December 31, 2022,~~June 30, 2023, members of ~~JRNY~~®~~, Nautilus’ personalized connected fitness platform,~~JRNY® reached ~~447,000,~~537,000, representing approximately ~~88%~~48% growth versus the same quarter last year. Of these members, ~~156,000~~150,000 were Subscribers, representing approximately ~~134%~~17% growth over the same period last year. ~~We define~~ ~~JRNY~~®Nautilus defines JRNY® Members as all individuals who have a ~~JRNY~~® JRNY® account and/or subscription, which includes Subscribers, their respective associated users, and users who consume free content. ~~We define Subscribers as~~A Subscriber is a person or household who paid for a subscription, ~~are~~is in a trial, or ~~have~~has requested a "pause"' to their subscriptions for up to three months.

• ~~In January 2023,~~Earlier this year, Nautilus introduced the ~~Company introduced an innovative feature set to its JRNY~~® ~~members~~JRNY® app with ~~the launch of~~ Motion Tracking – offering personalized coaching and feedback, automatic rep tracking, form guidance, and adaptive weight ~~targets. At release, the JRNY~~® ~~app with Motion Tracking offers workouts that are designed for use with Bowflex~~® ~~SelectTech~~® ~~552 or Bowflex~~® ~~SelectTech~~® ~~1090 dumbbells, enhancing Nautilus's strength offerings. It is optimized for use with an~~targets to all JRNY® memberships. Accessible via iOS or Android ~~tablet~~tablets and ~~JRNY~~®mobile devices, these embedded features are available to all JRNY® members ~~can access these features within~~with their existing membership and without the need for additional equipment.

•Leveraging proprietary technology and machine learning expertise from Nautilus’ acquisition of VAY, these new features ~~are enhancing~~bring enhanced value within the ~~JRNY~~® JRNY® platform, which ~~the Company believes will continue~~Nautilus expects to drive ~~JRNY~~®JRNY® membership ~~growth through~~growth. The Company has seen early success, as workouts with motion tracking are chosen by consumers twice as frequently as other workouts in the ~~remainder of fiscal 2023 and beyond.~~JRNY® platform.

•A JRNY® Mobile subscription, priced at an affordable $11.99 per month or $99 per year, is designed for members who like using a mobile device (phone or tablet) with a compatible BowFlex® or Schwinn connectable product. They also benefit from a wide range of whole body workouts that are versatile and can be used both at home and on the go.

•A JRNY® All-Access subscription, at $19.99 per month or $149 per year, expands a members’ usage to any of our BowFlex® built-in touchscreen cardio products.

Key Trends and Drivers of Performance

The following forward-looking statements reflect our full fiscal year ~~2023~~2024 expectations as of ~~February~~August 9, 2023, and are subject to risks and ~~uncertainties~~.uncertainties.

Full Year ~~2023~~

Due to decreased sales expectations and in line with our previously stated objective of minimizing cash consumption and returning to profitability, we have taken additional proactive cost reduction actions to drive profitability despite market headwinds. This includes reductions in workforce by approximately 15%. In addition, we have reduced our contracted labor, leveraging the flexibility of our variable operating model. These two actions are expected to yield annualized cost savings of approximately $30.0 million beginning in Q4 Fiscal 2023. We expect to incur restructuring and other one-time charges of approximately $3.0 million in the Q4 Fiscal 2023 to Q1 Fiscal 2024 ~~time frame. We may not be able to fully realize the cost savings and benefits initially anticipated from our cost reduction initiatives and the projected costs may be greater than expected.~~

•We expect full year net revenue to be in the range of ~~about~~ $270 million ~~compared~~ to $300 million, with the ~~previous range~~second half of ~~$315 million~~the year representing 60% to ~~$365 million. The decline in expected revenue is primarily due to lower expectations in our Retail segment.~~65% of full year net revenue.

•We are targeting JRNY® Members to be approximately ~~500,000~~625,000 at March 31, ~~2023.~~2024.

Table of Contents

Factors Affecting Our Performance

Our results of operations may vary significantly from period-to-period.

~~Table of Contents~~

Our revenues typically fluctuate due to the seasonality of our industry, customer buying patterns, product innovation, the nature and level of competition for health and fitness products, our ability to procure products to meet customer demand, the level of spending on, and effectiveness of, our media and advertising programs and our ability to attract new customers and maintain existing sales relationships. In addition, our revenues are highly susceptible to economic factors, including, among other things, the overall condition of the economy and the availability of consumer credit in both the U.S. and Canada. The COVID-19 pandemic created a heightened need for home-fitness products at an unprecedented rate and as the pandemic lessened there was a return to a more normal seasonality. We cannot predict with certainty the longer-term impacts of the COVID-19 pandemic and the change to consumer habits and sentiments and therefore, the impact on our results of operations is uncertain.

Our gross margins are being impacted by, among other things:

•Increased product costs, primarily driven by our increasing use of more expensive components in our products, which now include our connected fitness JRNY® platform.

•Fluctuations in the availability, and as a result the costs, of materials used to manufacture our products.

•Tariffs and expedited shipping and transportation costs.

•Fluctuations in cost associated with the acquisition or license of products and technologies, product warranty claims, fuel, foreign currency exchange rates, and changes in costs of other distribution or manufacturing-related services.

•~~Costs relating to the addition of a new distribution facility in Southern California prior to the exit from our Portland distribution facility.~~

•The efficiency and effectiveness of our organization and operations.

•~~A return to product discounting practices in place prior to the pandemic, which were temporarily suspended in part during the pandemic.~~

Our operating profits or losses may also be affected by the efficiency and effectiveness of our organization. Historically, our operating expenses have been influenced by media costs to produce and distribute advertisements of our products on television, websites and other media, facility costs, operating costs of our information and communications systems, product supply chain management, customer support and new product development activities. In addition, our operating expenses have been affected from time-to-time by asset impairment charges, restructuring charges and other significant unusual or infrequent expenses.

Forecasting for our business ~~during and following the COVID-19 pandemic~~ has proven to be challenging. Despite solid demand for our products as demonstrated in our Direct segment, headwinds in Retail re-orders persist as our retail partners continue to act conservatively in light of uncertainty in the economic environment. We have had significant difficulty in forecasting near-term demand and, as a result, our expected near-term operating performance. We are taking decisive actions to reduce our costs and realign our business with the short-term revenue outlook. See "Risk Factors - Strategic and Operational Risks - Our operating results could be adversely affected if we are unable to accurately forecast consumer demand for our products and services and adequately manage our inventory" in our 2023 Form 10-K.

As a result of the above and other factors, our period-to-period operating results may not be indicative of future performance. You should not place undue reliance on our operating results and should consider our prospects in light of the risks, expenses and difficulties typically encountered by us and other companies, both within and outside our industry. We may not be able to successfully address these risks and difficulties and, consequently, we cannot assure you of any future growth or profitability. For more information, see our discussion of ~~risk factors~~Risk Factors located at Part I, Item 1A of our ~~2022~~2023 Form ~~10-K as supplemented by our quarterly reports on Form 10-Q.~~10-K.

Discontinued Operations

Results from discontinued operations relate to the disposal of our former Commercial business, which was completed in April 2011. We reached substantial completion of asset liquidation as of December 31, 2012. Although there was no revenue related to the former Commercial business in the fiscal ~~2022~~2023 or year-to-date fiscal 2023 periods, we continued to incur product liability and other legal expenses associated with product previously sold into the Commercial channel.

In the second quarter of fiscal 2023, we completed the tax deregistration of a foreign entity which was part of the discontinued operations. As a result, the previously unrecognized tax benefit and associated accrued interest and penalties in the amount of $2.1 million was released and recorded as a component of income taxes from discontinued operations in the second quarter. There were no further significant activities or changes to our discontinued operations during the ~~third~~first quarter of fiscal ~~2023.~~2024.

~~Table of Contents~~

2925

Table of Contents

RESULTS OF OPERATIONS

Results of operations information was as follows (in thousands):

Three-Months Ended
December 31, Change
2022 2021 $ %
Net sales $ 98,079 $ 147,258 $ (49,179) (33.4) %
Cost of sales 75,219 117,342 (42,123) (35.9) %
Gross profit 22,860 29,916 (7,056) (23.6) %
Operating expenses:
Selling and marketing 17,203 32,395 (15,192) (46.9) %
General and administrative 10,859 11,456 (597) (5.2) %
Research and development 5,086 5,379 (293) (5.4) %
Total operating expenses 33,148 49,230 (16,082) (32.7) %
Operating loss (10,288) (19,314) 9,026 (46.7) %
Other expense:
Interest income 1 1 —
Interest expense (1,187) (354) (833)
Other, net 715 (789) 1,504
Total other expense, net (471) (1,142) 671
Loss from continuing operations before income taxes (10,759) (20,456) 9,697
Income tax expense (benefit) 322 (7,001) 7,323
Loss from continuing operations (11,081) (13,455) 2,374
Loss from discontinued operations, net of taxes (1) (44) 43
Net loss $ (11,082) $ (13,499) $ 2,417

~~Table of Contents~~


		Nine-Months Ended December 31,				Change					Three-Months Ended June 30,				Change
		2022		2021		$		%			2023		2022		$		%
Net sales	Net sales	$	218,354	$	469,810	$	(251,456)	(53.5)	%	Net sales	$	41,750	$	54,817	$	(13,067)	(23.8)	%
Cost of sales	Cost of sales	177,078		342,336		(165,258)		(48.3)	%	Cost of sales	33,101		47,860		(14,759)		(30.8)	%
Gross profit	Gross profit	41,276		127,474		(86,198)		(67.6)	%	Gross profit	8,649		6,957		1,692		24.3	%
Operating expenses:	Operating expenses:									Operating expenses:
Selling and marketing	Selling and marketing	39,493		75,634		(36,141)		(47.8)	%	Selling and marketing	6,001		12,891		(6,890)		(53.4)	%
General and administrative	General and administrative	34,317		39,355		(5,038)		(12.8)	%	General and administrative	8,894		12,463		(3,569)		(28.6)	%
Research and development	Research and development	16,315		15,882		433		2.7	%	Research and development	3,847		5,823		(1,976)		(33.9)	%
Restructuring and exit charges										Restructuring and exit charges	440		—		440		NM
Goodwill and intangible impairment charge	Goodwill and intangible impairment charge	26,965		—		26,965		NM		Goodwill and intangible impairment charge	—		26,965		(26,965)		(100.0)	%

Total operating expenses	Total operating expenses	117,090		130,871		(13,781)		(10.5)	%	Total operating expenses	19,182		58,142		(38,960)		(67.0)	%
Operating loss	Operating loss	(75,814)		(3,397)		(72,417)		2131.8	%	Operating loss	(10,533)		(51,185)		40,652		(79.4)	%
Other expense:	Other expense:									Other expense:
Interest income	Interest income	6		34		(28)				Interest income	14		1		13
Interest expense	Interest expense	(2,158)		(1,149)		(1,009)				Interest expense	(2,467)		(376)		(2,091)
Other, net	Other, net	(23)		(815)		792				Other, net	8,567		(514)		9,081
Total other expense, net	Total other expense, net	(2,175)		(1,930)		(245)				Total other expense, net	6,114		(889)		7,003
Loss from continuing operations before income taxes	Loss from continuing operations before income taxes	(77,989)		(5,327)		(72,662)				Loss from continuing operations before income taxes	(4,419)		(52,074)		47,655
Income tax expense (benefit)		8,573		(1,321)		9,894
Income tax expense										Income tax expense	505		8,096		(7,591)
Loss from continuing operations	Loss from continuing operations	(86,562)		(4,006)		(82,556)				Loss from continuing operations	(4,924)		(60,170)		55,246
Income (loss) from discontinued operations, net of taxes		2,101		(211)		2,312
Loss from discontinued operations										Loss from discontinued operations	—		(7)		7
Net loss	Net loss	$	(84,461)	$	(4,217)	$	(80,244)			Net loss	$	(4,924)	$	(60,177)	$	55,253
NM = Not meaningful

3126

Table of Contents

Results of operations information by segment and major product lines was as follows (dollars in thousands):


		Three-Months Ended December 31,						Change						Three-Months Ended June 30,						Change
		2022			2021			$			%			2023			2022			$			%
Net sales:	Net sales:												Net sales:
Direct net sales:	Direct net sales:												Direct net sales:
Cardio products(1)	Cardio products(1)	$	32,403		$	35,558		$	(3,155)		(8.9)	%	Cardio products(1)	$	12,518		$	17,133		$	(4,615)		(26.9)	%
Strength products(2)	Strength products(2)	14,326			25,147			(10,821)			(43.0)	%	Strength products(2)	9,328			9,343			(15)			(0.2)	%
Direct	Direct	46,729			60,705			(13,976)			(23.0)	%	Direct	21,846			26,476			(4,630)			(17.5)	%

Retail net sales:	Retail net sales:												Retail net sales:
Cardio products(1)	Cardio products(1)	$	20,949		$	37,199		$	(16,250)		(43.7)	%	Cardio products(1)	$	9,321		$	11,843		$	(2,522)		(21.3)	%
Strength products(2)	Strength products(2)	29,652			48,502			(18,850)			(38.9)	%	Strength products(2)	10,156			15,601			(5,445)			(34.9)	%
Retail	Retail	50,601			85,701			(35,100)			(41.0)	%	Retail	19,477			27,444			(7,967)			(29.0)	%

Royalty	Royalty	749			852			(103)			(12.1)	%	Royalty	427			897			(470)			(52.4)	%
		$	98,079		$	147,258		$	(49,179)		(33.4)	%		$	41,750		$	54,817		$	(13,067)		(23.8)	%

Cost of sales:	Cost of sales:												Cost of sales:
Direct	Direct	$	34,458		$	42,597		$	(8,139)		(19.1)	%	Direct	$	18,316		$	21,914		$	(3,598)		(16.4)	%
Retail	Retail	40,761			74,745			(33,984)			(45.5)	%	Retail	14,785			25,946			(11,161)			(43.0)	%

		$	75,219		$	117,342		$	(42,123)		(35.9)	%		$	33,101		$	47,860		$	(14,759)		(30.8)	%

Gross profit:	Gross profit:												Gross profit:
Direct	Direct	$	12,271		$	18,108		$	(5,837)		(32.2)	%	Direct	$	3,530		$	4,562		$	(1,032)		(22.6)	%
Retail	Retail	9,840			10,956			(1,116)			(10.2)	%	Retail	4,692			1,498			3,194			213.2	%
Royalty	Royalty	749			852			(103)			(12.1)	%	Royalty	427			897			(470)			(52.4)	%
		$	22,860		$	29,916		$	(7,056)		(23.6)	%		$	8,649		$	6,957		$	1,692		24.3	%
Gross profit margin:	Gross profit margin:												Gross profit margin:
Direct	Direct	26.3		%	29.8		%	(3.5)		ppts			Direct	16.2		%	17.2		%	(100)		basis points
Retail	Retail	19.4		%	12.8		%	6.6		ppts			Retail	24.1		%	5.5		%	1,860		basis points

Contribution:	Contribution:												Contribution:
Direct	Direct	$	(6,463)		$	(8,980)		$	2,517		(28.0)	%	Direct	$	(4,708)		$	(9,893)		$	5,185		(52.4)	%
Retail	Retail	3,447			3,270			177			5.4	%	Retail	382			(5,408)			5,790			(107.1)	%

Contribution rate:	Contribution rate:												Contribution rate:
Direct	Direct	(13.8)		%	(14.8)		%	1.0		ppts			Direct	(21.6)		%	(37.4)		%	15.8		ppts
Retail	Retail	6.8		%	3.8		%	3.0		ppts			Retail	2.0		%	(19.7)		%	21.7		ppts

(1) Cardio products include: connected-fitness bikes, the ~~Bowflex~~BowFlex® C6, VeloCore®, Schwinn® IC4, Max Trainer®, connected-fitness treadmills, other exercise bikes, ellipticals and subscription ~~services.~~services (applicable to Direct only).

(2) Strength products include: Bowflex® Home Gyms, ~~Bowflex~~BowFlex® SelectTech® dumbbells, kettlebell and barbell weights, and accessories.

~~Table of Contents~~

Nine-Months Ended December 31, Change
2022 2021 $ %
Net sales:
Direct net sales:
Cardio products(1)
$ 66,029 $ 89,394 $ (23,365) (26.1) %
Strength products(2)
31,657 72,560 (40,903) (56.4) %
Direct 97,686 161,954 (64,268) (39.7) %
Retail net sales:
Cardio products(1)
$ 47,345 $ 185,971 $ (138,626) (74.5) %
Strength products(2)
70,604 119,367 (48,763) (40.9) %
Retail 117,949 305,338 (187,389) (61.4) %
Royalty 2,719 2,518 201 8.0 %
$ 218,354 $ 469,810 $ (251,456) (53.5) %
Cost of sales:
Direct $ 77,751 $ 105,356 $ (27,605) (26.2) %
Retail 99,327 236,980 (137,653) (58.1) %
$ 177,078 $ 342,336 $ (165,258) (48.3) %
Gross profit:
Direct $ 19,935 $ 56,598 $ (36,663) (64.8) %
Retail 18,622 68,358 (49,736) (72.8) %
Royalty 2,719 2,518 201 8.0 %
$ 41,276 $ 127,474 $ (86,198) (67.6) %
Gross profit margin:
Direct 20.4 % 34.9 % (14.5) ppts
Retail 15.8 % 22.4 % (6.6) ppts
Contribution:
Direct $ (24,244) $ (4,056) $ (20,188) 497.7 %
Retail (994) 44,101 (45,095) (102.3) %
Contribution rate:
Direct (24.8) % (2.5) % (22.3) ppts
Retail (0.8) % 14.4 % (15.2) ppts

~~(1)~~ ~~Cardio products include: connected-fitness bikes, the Bowflex~~® ~~C6, VeloCore~~®~~, Schwinn~~® ~~IC4, Max Trainer~~®,~~connected-fitness treadmills, other exercise bikes, ellipticals andsubscription services.~~

~~(2)~~ ~~Strength products include: Bowflex~~® ~~Home Gyms, Bowflex~~® ~~SelectTech~~® ~~dumbbells, kettlebell and barbell weights, and accessories.~~

3327

Table of Contents

Sales and Gross Profit

Direct Segment

Comparison of Segment Results for the Three-Month Period Ended ~~December 31, 2022~~June 30, 2023 to ~~the for~~ the Three-Month Period Ended ~~December 31, 2021~~June 30, 2022

Net sales were ~~$46.7~~$21.8 million for the three-month period ended ~~December 31, 2022,~~June 30, 2023, compared to ~~$60.7~~$26.5 million, a decline of ~~23.0%~~17.5%, versus the same period in ~~2021, and up 30.2% compared to the same period in fiscal 2020.~~2022. Net sales decrease was primarily driven by ~~the return to pre-pandemic seasonal demand and pre-pandemic sales discounting practices.~~lower customer demand.

Cardio sales declined ~~8.9%~~26.9% versus the same period in ~~2021, and were up 9.1%, compared to the same period in fiscal 2020.~~2022. Lower cardio sales this quarter versus last year were primarily driven by lower demand for ~~Max Trainer~~® ~~and elliptical equipment.~~bikes. Strength product sales ~~declined 43.0%~~were relatively flat versus the same period ~~in 2021, and increased 131.0% compared to the same period in fiscal 2020. Lower strength sales this quarter versus~~ last ~~year were primarily driven by lower demand for SelectTech~~® ~~weights.~~year.

~~The Direct segment had $2.1 million of backlog as of December 31, 2022. This amount represents unfulfilled consumer orders net of current promotional programs and sales discounts.~~

Gross profit margin was ~~26.3%~~16.2% for the three-month period ended ~~December 31, 2022~~June 30, 2023 versus ~~29.8%~~17.2% for the same period in ~~2021.~~2022. The ~~3.5~~1.0 ppt decrease in gross margin was primarily driven by: unfavorable absorption of JRNY® COGs (-8 ppts), increased discounting ~~(-4~~(-2 ppts) and higher outbound freight (-2 ppts), ~~partially~~ offset by ~~a decrease in other~~lower landed product costs (+~~0.5 ppt)~~7 ppts) and favorable logistics overhead absorption (+3 ppts). Gross profit was ~~$12.3~~$3.5 million, a decrease of ~~32.2%~~22.6% versus the same period in ~~2021.~~2022.

Segment contribution loss was ~~$6.5~~$4.7 million for the three-month period ended ~~December 31, 2022,~~June 30, 2023, or ~~13.8%~~21.6% of sales, compared to segment contribution loss of ~~$9.0~~$9.9 million, or ~~14.8%~~37.4% of sales for the same period in ~~2021.~~2022. The improvement was primarily driven by decreased media spend and lower operating expenses, partially offset by lower gross profit, as explained above. Advertising expenses were ~~$8.9~~$0.9 million compared to ~~$16.1~~$5.2 million for the same period in ~~2021.~~2022.

Combined consumer credit approvals by our primary and secondary U.S. third-party financing providers for the third quarter of fiscal 2023 were ~~52.8%~~50.7%, compared to ~~60.3%~~53.8% for the same period in ~~2021.~~2022. The decrease in approvals reflects lower credit quality applications.

Retail Segment

Comparison of Segment Results for the Three-Month Period Ended ~~December 31, 2022~~June 30, 2023 to ~~the for~~ the Three-Month Period Ended ~~December 31, 2021~~June 30, 2022

Net sales for the three-month period ended ~~December 31, 2022~~June 30, 2023 were ~~$50.6~~$19.5 million, compared to ~~$85.7~~$27.4 million, a decline of ~~41.0%~~29.0%, for the same period in ~~2021. Net sales were down 5.6% compared to the same period in fiscal 2020, excluding sales related to the Octane brand.~~2022. Retail segment sales outside the United States and Canada were ~~down 66.7%~~up 69.1% versus ~~last.~~the same period last year. The net sales decrease compared to last year iswas primarily driven by lower ~~cardio sales~~demand as retailers work through ~~higher than normal~~higher-than-normal inventory ~~levels and the return to pre-pandemic seasonal demand.~~levels.

Cardio sales for the three-month period ended ~~December 31, 2022~~June 30, 2023 decreased by ~~43.7%. Excluding sales related to Octane, cardio sales were down 40.5%~~21.3% compared to the same period ~~in fiscal 2020.~~of last year. Lower cardio sales this quarter were primarily driven by lower demand for ~~Max Trainer~~® ~~and elliptical equipment.~~bikes. Strength product sales declined by ~~38.9%~~34.9% versus last year. Lower strength sales this quarter versus last year were primarily driven by lower demand for ~~home gyms. Strength sales were up 61.1% compared to the same period in fiscal 2020, led by the popular~~ SelectTech® weights.

As of December 31, 2022, the Retail segment's backlog totaled $16.8 million. This amount represents customer orders for future shipments and are net of contractual rebates and consideration payable to applicable Retail customers.

Gross profit margins were ~~19.4%~~24.1% for the three-month period ended ~~December 31, 2022,~~June 30, 2023, up from ~~12.8%~~5.5% for the same period in ~~2021.~~2022. The ~~6.6~~18.6 ppt increase in gross margin was primarily due to ~~decrease in inventory adjustments~~

~~Table of Contents~~

~~(+5~~lower landed product costs (+13 ppts) and decreased discounting (+47 ppts), partially offset by unfavorable logistics overhead absorption (-1 ppt)~~, and an increase in other costs (-1 ppt)~~. Gross profit was ~~$9.8~~$4.7 million, ~~a decrease~~an increase of ~~10.2%~~213.2% versus the same period in ~~2021.~~2022.

Segment contribution income for the three-month period ended ~~December 31, 2022~~June 30, 2023 was ~~$3.4~~$0.4 million, or ~~6.8%~~2.0% of sales, compared to segment contribution ~~income~~loss of ~~$3.3~~$5.4 million, or ~~3.8%~~19.7% of sales for the same period in ~~2021.~~2022. The ~~increase~~improvement was primarily driven by ~~cost savings and~~lower operating expenses, partially offset by lower gross profit.

Royalty

Royalty income decreased by ~~$0.1~~$0.5 million, or ~~12.1%~~52.4%, to ~~$0.7~~$0.4 million for the three-month period ended ~~December 31, 2022,~~June 30, 2023, compared to the same period of ~~2021,~~2022, primarily due to decreased royalty ~~settlements.~~income as a result of the sale of the Nautilus brand trademarks and related royalty licenses.

~~Sales and Gross Profit~~

~~Direct Segment~~

~~Comparison of Segment Results for the Nine-Month Period Ended December 31, 2022 to the Nine-Month Period Ended December 31, 2021~~

Net sales were $97.7 million for the nine-month period ended December 31, 2022, compared to $162.0 million, a decline of 39.7% versus the same period in 2021, and up 33.9% compared to the same period in fiscal 2020. The net sales decrease compared to last year was primarily driven by the return to pre-pandemic seasonal demand and pre-pandemic sales discounting practices.

Cardio sales declined 26.1% versus the same period in 2021, and were up 13.4% compared to the same period in fiscal 2020. Lower cardio sales were primarily driven by lower bike demand. Strength product sales declined 56.4% versus the same period in 2021, and increased 115.1% compared to the same period in fiscal 2020. Lower strength sales this year were primarily driven by lower demand for SelectTech® ~~weights.~~

Gross profit margin was 20.4% for the nine-month period ended December 31, 2022 versus 34.9% for the same period in 2021. The 14.5 ppt decrease in gross margin was primarily due to increased discounting (-8 ppts), increased investments in JRNY® (-3 ppts), unfavorable logistics overhead absorption (-3 ppts), increased product costs (-2 ppts), partially offset by lower outbound freight (+1 ppt). Gross profit was $19.9 million, down 64.8% versus the same period in 2021.

Segment contribution loss was $24.2 million for the nine-month period ended December 31, 2022, compared to segment contribution loss of $4.1 million for the same period in 2021. The decline was primarily driven by lower gross profit, as explained above, offset by decreased media spend. Advertising expenses were $16.7 million compared to $30.8 million for the same period in 2021.

~~Retail Segment~~

~~Comparison of Segment Results for the Nine-Month Period Ended December 31, 2022 to the Nine-Month Period Ended December 31, 2021~~

Net sales for the nine-month period ended December 31, 2022 were $117.9 million, down 61.4%, from $305.3 million for the same period in 2021. Excluding sales related to Octane, net sales were flat compared to the same period in fiscal 2020. Retail segment sales outside the United States and Canada were down 77.6% versus last year. The net sales decrease compared to last year is primarily driven by the return to pre-pandemic seasonal demand, lower cardio sales, and higher sales discounting as retailers work through higher than normal inventory levels.

Cardio sales for the nine-month period ended December 31, 2022 decreased by 74.5%. Excluding sales related to Octane, cardio sales were down 39.8% compared to the same period in fiscal 2020. Lower cardio sales this year were primarily driven by lower bike demand. Strength product sales declined by 40.9% versus last year. Lower strength sales this year were primarily driven by lower demand for weights. Strength sales were up 80.4% compared to the same period in fiscal 2020, led by the popular SelectTech® ~~weights.~~

Gross profit margins were 15.8% for the nine-month period ended December 31, 2022, down from 22.4% for the same period in 2021. The 6.6 ppt decrease in gross margin was primarily due to increased discounting (-4 ppts),

3528

Table of Contents

~~and unfavorable logistics overhead absorption (-4 ppts), partially offset by a decrease in other costs (+1 ppt). Gross profit was $18.6 million, a decrease of 72.8% versus the same period in 2021.~~

Segment contribution loss for the nine-month period ended December 31, 2022 was $1.0 million, or 0.8% of sales, compared to segment contribution income of $44.1 million, or 14.4% of sales for the same period in 2021, primarily driven by lower gross profit as explained above.

~~Royalty~~

~~Royalty income increased by $0.2 million, or 8.0%, to $2.7 million for the nine-month period ended December 31, 2022, compared to the same period of 2021, primarily due to royalty settlements.~~

Selling and Marketing

Selling and marketing expenses include payroll, employee benefits, and other headcount-related expenses associated with sales and marketing personnel, and the costs of media advertising, promotions, trade shows, seminars, sales incentives related to our JRNY® platform and other programs.

Selling and marketing information was as follows (dollars in thousands):


		Three-Months Ended December 31,						Change				Three-Months Ended June 30,						Change
		2022			2021			$		%		2023			2022			$		%
Selling and marketing	Selling and marketing	$	17,203		$	32,395		$	(15,192)	(46.9)%	Selling and marketing	$	6,001		$	12,891		$	(6,890)	(53.4)%
As % of net sales	As % of net sales	17.5		%	22.0		%				As % of net sales	14.4		%	23.5		%

Nine-Months Ended December 31, Change
2022 2021 $ %
Selling and marketing $ 39,493 $ 75,634 $ (36,141) (47.8)%
As % of net sales 18.1 % 16.1 %

The ~~$15.2~~$6.9 million decrease in selling and marketing expenses for the three-month period ended ~~December 31, 2022~~June 30, 2023 as compared to the same period of ~~2021~~2022 was primarily related to a ~~decrease of $12.7 million in media spend, and a decrease of $1.3 million in other variable selling and marketing expenses due to decreased sales.~~

~~The $36.1 million decrease in selling and marketing expenses for the nine-month period ended December 31, 2022 as compared to the same period of 2021 was primarily due to a $28.0~~$4.0 million decrease in media spend, ~~a $6.6~~$1.3 million decrease in other costs, $0.7 million decrease in other variable selling and marketing expenses due to decreased sales, $0.5 million decrease in personnel expenses, and ~~$2.1~~$0.4 million decrease in ~~other cost savings, partially offset by an increase of $0.6 million JRNY~~® ~~related investments.~~contracted services. We expect variable selling and marketing expenses to continue to ~~fluctuate~~flex with sales.

Media advertising expense is the largest component of selling and marketing and was as follows (dollars in thousands):
Three-Months Ended
December 31, Change
2022 2021 $ %
Total advertising $ 9,515 $ 22,254 $ (12,739) (57.2)%


	Three-Months Ended June 30,				Change
	2023		2022		$		%


Total advertising	$	1,105	$	5,120	$	(4,015)	(78.4)%

Nine-Months Ended December 31, Change
2022 2021 $ %
Total advertising $ 18,330 $ 46,296 $ (27,966) (60.4)%

The ~~$12.7~~$4.0 million decrease in media advertising expense for the three-month period ended ~~December 31, 2022,~~June 30, 2023, as compared to the same period of ~~2021~~2022 reflects ~~a return to more historical, pre-pandemic levels of~~increased cost control while maintaining advertising

~~Table of Contents~~

support to preserve market ~~share and control costs.~~share. Advertising as a percentage of selling and marketing for the three-month period ended ~~December 31, 2022~~June 30, 2023 was ~~55.3%~~18.4% as compared to ~~68.7%~~39.7% for the same quarter last ~~year and 53.0% for the same period in fiscal 2020.~~

The $28.0 million decrease in media advertising expense for the nine-month period ended December 31, 2022, as compared to the same period of 2021 reflects a return to more historical, pre-pandemic levels of advertising support to preserve market share and control costs. Advertising as a percentage of selling and marketing for the nine-month period ended December 31, 2022 was 46.4% as compared to 61.2% for the same quarter last year and 43.8% for the same period in fiscal 2020.year.

General and Administrative

General and administrative expenses include payroll, employee benefits, stock-based compensation expense, and other headcount-related expenses associated with finance, legal, facilities, certain human resources and other administrative personnel, and other administrative fees.

General and administrative was as follows (dollars in thousands):

Three-Months Ended
December 31, Change
2022 2021 $ %
General and administrative $ 10,859 $ 11,456 $ (597) (5.2)%
As % of net sales 11.1 % 7.8 %

Nine-Months Ended December 31, Change
2022 2021 $ %
General and administrative $ 34,317 $ 39,355 $ (5,038) (12.8)%
As % of net sales 15.7 % 8.4 %


	Three-Months Ended June 30,						Change
	2023			2022			$		%
General and administrative	$	8,894		$	12,463		$	(3,569)	(28.6)%
As % of net sales	21.3		%	22.7		%

The ~~$0.6~~$3.6 million decrease in general and administrative expenses for the three-month period ended ~~December 31, 2022~~June 30, 2023 as compared to the same period of ~~2021~~2022 was primarily due to ~~decreased~~A $3.1 million decrease in personnel expenses, $0.3 million decrease in legal fees, and $0.2 million decrease in other expenses.

The ~~$5.0 million~~ decrease in general and administrative as a percentage of net sales was due to the decreases in spending being more than offset by lower net sales. We expect general and administrative expenses ~~for the nine-month period ended December 31, 2022 as~~to be a lower percentage of net sales this fiscal year, compared to the same period of 2021 was primarily due to a $4.7 million prior year loss contingency related to a legal settlement, a $1.5 million decrease in legal expenses, and $1.5 million in other cost savings, offset by an increase of $2.6 million of JRNY® ~~related expenses.~~last fiscal year.

Research and Development

Research and development expenses include payroll, employee benefits, other headcount-related expenses and information technology associated with product development.

Table of Contents

Research and development was as follows (dollars in thousands):


		Three-Months Ended December 31,						Change				Three-Months Ended June 30,						Change
		2022			2021			$		%		2023			2022			$		%
Research and development	Research and development	$	5,086		$	5,379		$	(293)	(5.4)%	Research and development	$	3,847		$	5,823		$	(1,976)	(33.9)%
As % of net sales	As % of net sales	5.2		%	3.7		%				As % of net sales	9.2		%	10.6		%

~~Table of Contents~~

Nine-Months Ended December 31, Change
2022 2021 $ %
Research and development $ 16,315 $ 15,882 $ 433 2.7%
As % of net sales 7.5 % 3.4 %

The $2.0 million decrease in research and development expenses for the three-month period ended ~~December 31, 2022,~~June 30, 2023, as compared to the same period of ~~2021, were relatively flat and represented a higher percentage of sales this quarter~~2022, was primarily due to ~~timing~~a $1.4 million reduction of ~~technical projects~~contracted services and ~~increased investments~~$0.7 million decrease in ~~JRNY~~®~~, our digital platform.~~personnel expenses, partially offset by a $0.1 million increase in other costs.

The ~~increase~~decrease in research and development as a percentage of net sales was due to the decreases in spending being more than offset by lower net sales. We expect research and development expenses ~~for the nine-month period ended December 31, 2022 as~~to be a lower percentage of net sales this fiscal year, compared to ~~the same period in 2021, was driven by the timing of technical projects and increased investments in JRNY~~®~~, our digital platform.~~last fiscal year.

Goodwill and Intangible Impairment Charge

~~In accordance with ASC 350 — Intangibles — Goodwill and Other, we perform a goodwill and indefinite-lived asset impairment evaluation during the fourth quarter of each year. However, as~~As a result of the decline in our market value relative to the market and our industry, which was identified as a triggering event, we performed an interim evaluation and a market capitalization reconciliation during the first quarter of fiscal 2023 which resulted in a non-cash goodwill and indefinite-lived intangible assets impairment charge of $27.0 million.

ASC 350 requires us to make significant assumptions and estimates about the extent and timing of future cash flows, discount rates, growth rates and terminal value. The cash flows are estimated over a significant future period of time, which makes those estimates and assumptions subject to an even higher degree of uncertainty. We also use market valuation models and other financial ratios, which require us to make certain assumptions and estimates regarding the applicability of those models to our assets and businesses.

In accordance with ASC 360 — Property, Plant, and Equipment and other long-lived assets, we perform a test for recoverability when triggering events occur. No impairment was recognized in the quarter ended December 31, 2022.

For additional information related to our goodwill and intangible impairment charge, see Note 8.9.

Operating Loss

Operating loss for the three-months ended ~~December 31, 2022~~June 30, 2023 was ~~$10.3~~$10.5 million, a decrease of ~~$9.0~~$40.7 million, or ~~46.6%~~79.4%, as compared to an operating loss of ~~$19.3~~$51.2 million for the same period of ~~2021.~~2022. The improvement in results was primarily driven by higher gross profit ~~and higher gross margins~~ during the period as well as the goodwill and intangible impairment charge in the prior year period.

~~Operating loss~~Interest Expense

Interest expense for the ~~nine-month period~~three-months ended ~~December 31, 2022~~June 30, 2023 was ~~$75.8~~$2.5 million, an increase of ~~$72.4~~$2.1 million, or 556.1%, as compared to an ~~operating loss~~interest expense of ~~$3.4~~$0.4 million for the same period of ~~2021.~~2022. The increase was primarily ~~driven by~~due to a ~~goodwill~~$0.9 million loss from the SLR Term Loan amendment, a $0.6 million loss from the ABL Credit Facility amendment and ~~intangible impairment charge of $27.0~~$0.7 million ~~and lower gross profit associated with lower sales and lower gross margins during the period.~~in interest related payments.

Other, Net

Other, net relates to the effect of exchange rate fluctuations with the U.S. and our foreign subsidiaries and ~~a debt extinguishment loss.~~intellectual property asset sale.

Other, net was as follows (in thousands):

Three-Months Ended
December 31, Change
2022 2021 $ %
Other, net $ 715 $ (789) $ 1,504 (190.6)%


	Three-Months Ended June 30,				Change
	2023		2022		$		%
Other, net	$	8,567	$	(514)	$	9,081	(1,766.7)%

~~Table~~The $9.1 million increase in Other, net is primarily due to a $6.4 million net gain on the sale of ~~Contents~~

intellectual property, a $2.2 million net gain on the sale of equity investments, and a $0.5 million prior year loss in foreign exchange.

Nine-Months Ended December 31, Change
2022 2021 $ %
Other, net $ (23) $ (815) $ 792 (97.2)%

Income Tax Expense

Income tax expense includes U.S. and international income taxes, and interest and penalties on uncertain tax positions.

Table of Contents

Income tax expense ~~(benefit)~~ was as follows (in thousands):


		Three-Months Ended December 31,						Change				Three-Months Ended June 30,						Change
		2022			2021			$		%		2023			2022			$		%
Income tax expense (benefit)		$	322		$	(7,001)		$	7,323	(104.6)%
Income tax expense											Income tax expense	$	505		$	8,096		$	(7,591)	(93.8)%
Effective tax rate	Effective tax rate	(3.0)		%	34.2		%				Effective tax rate	(11.4)		%	(15.5)		%

Nine-Months Ended December 31, Change
2022 2021 $ %
Income tax expense (benefit) $ 8,573 $ (1,321) $ 9,894 (749.0)%
Effective tax rate (11.0) % 24.8 %

Income tax expense for the ~~three~~three-month period ended June 30, 2023 was $0.5 million compared to $8.1 million last year. Expenses this quarter are primarily driven by foreign related taxes and ~~nine-month periods~~FIN 48 reserves related to an income tax audit. No tax benefit associated with domestic losses was recognized due to the U.S. deferred tax asset valuation allowance position established last year. Income tax expense for the three-months ended ~~December 31,~~June 30, 2022 was primarily a result of ~~activities in foreign jurisdictions, as well as~~ the ~~recording of a~~ U.S. deferred tax asset valuation ~~allowance in the amount of $2.8 million and $20.6 million, respectively,during these periods.~~allowance.

The effective tax rates from continuing operations for the three and nine-month periods ended December 31, 2022 were primarily as a result of the aforementioned U.S deferred tax asset valuation allowance to reduce the existing U.S. domestic deferred tax assets to their anticipated realizable value.

~~Income tax benefits and effective tax rates for the three and nine-months ended December 31, 2021 were primarily due to the loss generated in the U.S.~~

Loss from Continuing Operations

Loss from continuing operations was ~~$11.1~~$4.9 million for the three-months ended ~~December 31, 2022,~~June 30, 2023, or ~~$0.35~~$0.15 per diluted share, compared to loss from continuing operations of ~~$13.5~~$60.2 million, or ~~$0.43~~$1.92 per diluted share, for the three-months ended ~~December 31, 2021.~~June 30, 2022. The decrease in loss from continuing operations was primarily due to higher gross profit as discussed in more detail ~~above.~~

~~Loss from continuing operations was $86.6 million for~~above, as well as the ~~nine-month period ended December 31, 2022, or $2.75 per diluted share, compared to $4.0 million, or $0.13 per diluted share, for~~goodwill and intangible impairment charge in the ~~nine-months ended December 31, 2021. The increase in loss from continuing operations was primarily due to lower gross profit and higher operating expenses as discussed in more detail above.~~prior year period.

Net Loss

Net loss was ~~$11.1~~$4.9 million for the three-months ended ~~December 31, 2022,~~June 30, 2023, compared to net loss of ~~$13.5~~$60.2 million for the three-months ended ~~December 31, 2021.~~June 30, 2022. Net loss per diluted share was ~~$0.35~~$0.15 for the three-months ended ~~December 31, 2022,~~June 30, 2023, compared to net loss per diluted share of ~~$0.43~~$1.92 for the three-months ended ~~December 31, 2021.~~June 30, 2022.

Net loss was $84.5 million for the nine-month period ended December 31, 2022, compared to $4.2 million for the nine-months ended December 31, 2021. Net loss per diluted share was $2.68 for the nine-month period ended December 31, 2022, compared to net loss per diluted share of $0.14 for the nine-months ended December 31, 2021.

3931

Table of Contents

LIQUIDITY AND CAPITAL RESOURCES

Our future capital requirements may vary materially from those currently planned and will depend on many factors, including our levels of revenue, the timing and extent of spending on research and development efforts and other business initiatives, the expansion of sales and marketing activities, the timing of new product introductions, market acceptance of our products, and overall economic conditions. To the extent that current and anticipated future sources of liquidity are insufficient to fund our future business activities and requirements, including if we are able to maintain compliance with debt-related financial covenants, we may be required to seek additional equity or debt financing. The sale of additional equity would result in additional dilution to our shareholders. The incurrence of debt financing would result in debt service obligations and the instruments governing such debt could provide for operating and financing covenants that would restrict our operations.

As of ~~December 31, 2022,~~June 30, 2023, we had ~~$16.5~~$18.3 million of cash, cash equivalents and restricted cash, and ~~$26.9~~$9.5 million was available for borrowing under the WF ABL Revolving Facility, compared to ~~$14.2~~$18.3 million of cash, cash equivalents and restricted cash, and ~~$65.8~~$14.9 million available for borrowing under the WF ABL Revolving Facility as of March 31, ~~2022.~~2023.

~~Despite solid demand~~During the quarter ended June 30, 2023, we sold 3,525,000 shares of our common stock for $1.22 per share and pre-funded warrants to purchase up to 573,362 shares of our common stock at $1.2199 per share for net proceeds of $4.6 million after offering expenses. The pre-funded warrants have an exercise price of $0.0001 per share, are immediately exercisable and will expire when exercised in ~~our Direct segment, headwinds in our Retail segment persist~~full. See Note 12for additional information.

During the quarter ended June 30, 2023, the Company completed the sale of intellectual property for $10.5 million as ~~our retail partners~~part of its ongoing comprehensive strategic review. The sale of these assets, which included the Nautilus brand trademark assets and related licenses, will continue to ~~take heavily conservative inventory positions~~streamline the Company’s brand focus and enhance its financial flexibility. The carrying value of the intangible assets sold was $3.7 million and the resulting gain, net of transaction costs, was recorded in ~~light of uncertainty~~Other Income and in the ~~economic environment. In response, we have taken~~Consolidated Statements of Cash Flows from investing activities as proceeds from sale of intellectual property for the quarter ended June 30, 2023.

During the quarter ended June 30, 2023, the Company completed the sale of Vi Labs for $2.3 million as part of its ongoing comprehensive strategic ~~actions~~review. The sale of this equity investment will continue to ~~reduce our~~streamline the Company’s brand focus and enhance its financial flexibility. The carrying value of the assets sold was $0.0 and transaction costs of the sale was $0.1 million. The resulting gain of $2.2 million, net of transaction costs, was recorded in the Consolidated Statements of Operations as Other income and ~~realign our business, allowing us to mitigate these near-term challenges, enhance cash flow and drive long-term profitable growth.~~in the Consolidated Statements of Cash Flows investing activities as Proceeds from sale of equity investment for the quarter ended June 30, 2023.

We expect our cash, cash equivalents, restricted cash and amounts available for borrowing under our SLR ~~Credit Facility~~Term Loan and WFABL Credit Facility as of ~~December 31, 2022,~~June 30, 2023, along with cash expected to be generated from operations, to be sufficient to fund our operating and capital requirements for at least the next twelve months. ~~We expect to incur restructuring and other one-time charges of approximately $3.0 million in the Q4 Fiscal 2023 to Q1 Fiscal 2024 time frame.~~

If forecasted sales are not achieved, ~~as planned,~~ our semi-variable operating model will allow additional cost cutting measures and additional working capital levers will be executed.

Cash used in operating activities was ~~$11.8~~$2.4 million for the ~~nine-month~~three-month period ended ~~December 31, 2022,~~June 30, 2023, compared to cash used in operating activities of ~~$91.6~~$6.0 million for the ~~nine-month~~three-month period ended ~~December 31, 2021.~~June 30, 2022. The improvement in cash flows from operating activities for the ~~nine-month~~three-month period ended ~~December 31, 2022~~June 30, 2023 as compared to the same period of ~~2021~~2022 was primarily due to changes in our operating assets and liabilities discussed below and a decreased net loss, offset by a decrease in non-cash ~~charges and an increased net loss.~~charges.

Trade receivables decreased to ~~$42.7~~$13.2 million as of ~~December 31, 2022,~~June 30, 2023, compared to ~~$61.5~~$21.5 million as of March 31, ~~2022,~~2023, primarily due to lower ~~sales.~~sales volumes driven by seasonality.

I~~nventory~~Inventory was ~~$77.3~~$39.8 million as of ~~December 31, 2022,~~June 30, 2023, down ~~30%~~15% compared to ~~$111.2~~$46.6 million as of March 31, ~~2022~~2023 and down ~~40%~~62% compared to ~~$128.1~~$103.9 million as of ~~December 31, 2021.~~June 30, 2022. The decrease in inventory was driven by sell-through and strong inventory management as we continue to right-size inventory levels. About ~~18%~~9% of inventory as of ~~December 31, 2022~~June 30, 2023 was in-transit.

P~~repaid~~Prepaid and other current assets ~~decreased by $1.5 million to $13.0 million,~~changes were immaterial, compared to ~~$14.5 million as of~~ March 31, ~~2022, primarily due to a $2.1 million decrease in prepaid expenses, partially offset by a $0.6 million increase in duty drawback receivables and a $0.2 million increase in hedging derivatives assets.~~2023.

Table of Contents

Trade payables decreased by ~~$18.2~~$8.9 million to ~~$35.0~~$20.5 million as of ~~December 31, 2022, compared to $53.2 million as of March 31, 2022, primarily due to reduced inventory and media payables.~~

A~~ccrued liabilities decreased by $12.0 million to $17.4 million as of December 31, 2022,~~June 30, 2023, compared to $29.4 million as of March 31, ~~2022,~~2023, primarily due to lowered operating expense accruals due to lower sales volumes driven by seasonality and expense control efforts.

Accrued liabilities decreased by $2.8 million to $12.7 million as of June 30, 2023, compared to $15.6 million as of March 31, 2023, primarily due to a ~~$4.2 million legal settlement payment, decreases in accrued off-site materials of $3.0 million and a $2.0~~$0.7 million decrease in accruals for Finance fees and return reserves due to slow season sales, $0.9 million decrease in deferrals for JRNY® revenue due to change in free trials, $0.7 million reduction in payroll ~~related liabilities.~~accruals due to payroll schedule resulting in fewer days accrued and $0.7 million decrease in Vi fee accrual in the first quarter of fiscal 2024 as compared to the fourth quarter of fiscal 2023 due to seasonal sales declines.

Cash used in investing activities of ~~$10.7~~$11.7 million for the ~~nine-month~~three-month period ended ~~December 31, 2022~~June 30, 2023 was primarily due to $10.5 million from the sale of intellectual property, $2.4 million from the sale of an equity investment, partially offset by $1.2 million capital purchases related to our digital platform. We anticipate spending between ~~$12.0~~$4.0 million and ~~$14.0~~$4.5 million in fiscal ~~2023~~2024 for digital platform enhancements, systems integration, and production tooling.

~~Table of Contents~~

Cash provided by financing activities of ~~$27.6~~$9.5 million for the ~~nine-month~~three-month period ended ~~December 31, 2022~~June 30, 2023 was primarily related to ~~proceeds from long-term debt offset by~~$12.9 million in payments on long-term ~~debt.~~debt and $0.8 million in payments of debt issuance costs, partially offset by $4.5 million proceeds from the sale of common stock and warrants discussed above.

Free Cash Flow

Free cash flow is a non-GAAP financial measure. We define free cash flow as net cash provided by (used in) operating activities minus capital expenditures. We believe that, when viewed with our GAAP results, free cash flow provides management, investors and other users of our financial information with a more complete understanding of factors and trends affecting our cash flows. We believe free cash flow provides useful additional information to users of our financial information and is an important metric because it represents a measure of how much cash ~~a company has~~we have available for discretionary and non-discretionary items after the deduction of capital expenditures. ~~We require regular capital expenditures including technology improvements to automate processes, engage with customers, and optimize our supply chain.~~ We use this metric internally, as we believe our sustained ability to generate free cash flow is an important driver of value creation. However, this non-GAAP financial measure is not intended to supersede or replace our GAAP results.

The following table ~~reconciles~~presents a reconciliation of free cash flow, a non-GAAP financial measure, ~~from a GAAP~~to Net cash provided by (used in) operating activities, the most directly comparable financial measure prepared in accordance with GAAP (in thousands):

Three-Months Ended
December 31, Nine-Months Ended December 31,
2022 2021 2022 2021
Net cash used in operating activities $ (2,184) $ (34,829) $ (11,780) $ (91,583)
Purchase of property, plant and equipment (3,186) (4,151) (10,697) (9,136)
Free cash flow $ (5,370) $ (38,980) $ (22,477) $ (100,719)
Net loss $ (11,082) $ (13,499) $ (84,461) $ (4,217)
Free cash flow as percentage of net loss 48.5 % 288.8 % 26.6 % 2,388.4 %


	Three-Months Ended June 30,
	2023			2022
Net cash used in operating activities	$	(2,365)		$	(5,980)
Purchase of property, plant and equipment	(1,178)			(3,381)
Free cash flow	$	(3,543)		$	(9,361)
Net loss	$	(4,924)		$	(60,177)
Free cash flow as percentage of net loss	72.0		%	15.6		%

Financing Arrangements

Entry into Amended Term Loan Facility

The SLR Credit Agreement contains customary affirmative and negative covenants for financings of this type, including, among other terms and conditions, delivery of financial statements, reports and maintenance of corporate existence, availability subject to a calculated borrowing base, as well as limitations and conditions on our ability to: create, incur, assume or be liable for indebtedness; dispose of assets outside the ordinary course; acquire, merge or consolidate with or into another person or entity; create, incur or allow any lien on any of our property; make investments; or pay dividends or make distributions, in each case subject to certain exceptions. The financial covenants set forth in the SLR Credit Agreement initially requireAmendment permits us to ~~(a) maintain~~enter into certain asset disposition transactions (the “Specified Transactions”) and a license amendment transaction (the “License Amendment Transaction”). In connection therewith, the minimum excess availability ~~of at least~~covenant will step-down from the greater ~~of (i)~~of: $10.0 million ~~(subject to increase set forth in the SLR Credit Agreement related to utilization of any incremental term loan facilities thereunder) or (ii)~~and 12.5% of the ~~sum of (x)~~Combined Line Cap, to the ~~line cap under the Wells Fargo Credit Agreement (calculated without giving effect to any term pushdown reserve) plus (y) the lesser of (A) the outstanding principal balance~~greater of: (a) $9.0 million and 12.5% of the ~~loans under the SLR Credit Agreement and (B) the borrowing base under the SLR Credit Agreement (the “Combined~~Combined Line ~~Cap”). From and~~Cap after the ~~date on which both~~consummation of the ~~fixed charge~~first Specified Transaction and (b) $7.0 million and 12.5% of the Combined Line Cap after the

4133

Table of Contents

~~coverage ratio for~~consummation of each subsequent Specified Transaction. We prepaid $11.8 million of principal outstanding on the ~~previous 12-month period is at least 1.00~~Term Loan with the cash proceeds received from the consummation of the Specified Transactions and the License Amendment Transaction.

Amendment to ~~1.00 and availability under the~~Existing ABL Credit Agreement

On April 25, 2023, we entered into an amendment (the “ABL Amendment”) to our existing Credit Agreement with Wells Fargo Bank, National Association ("Wells Fargo") dated as of January 31, 2020 (as amended, the “ABL Credit Facility Agreement ~~is equal~~”) with Wells Fargo Bank, National Association (“Wells Fargo”). The ABL Amendment permits us to ~~or greater than $20.0 million, we shall no longer be~~enter into the Specified Transactions and the License Amendment Transaction, subject to asatisfaction of the terms and conditions set forth therein. In connection therewith, the minimum excess availability covenant ~~but rather would be required to maintain a fixed charge coverage ratio of at least 1.00:1.00 tested when availability under the Wells Fargo Credit Agreement is less than~~will step-down from the greater ~~of (i)~~of: $10.0 million and 12.5% of the Combined Line Cap, ~~(excluding~~to the ~~effect, if any, of any term pushdown reserve),~~greater of: (a) $9.0 million and ~~(ii) $11.0 million, calculated as~~12.5% of the ~~last day~~Combined Line Cap after the consummation of the first Specified Transaction and (b) $7.0 million and 12.5% of the Combined Line Cap after the consummation of each ~~fiscal quarter (the “Financial Covenants”).~~subsequent Specified Transaction. In addition, the ~~SLR Credit Agreement includes customary events of default, including but not limited~~ABL Amendment reduced the maximum revolving loan commitment amount from $100 million to the nonpayment of principal and interest when due thereunder, breaches of representations and warranties, noncompliance with covenants, acts of insolvency and default on indebtedness held by third parties (subject to certain limitations and cure periods).$60 million.

~~Amendment to Existing WF ABL Revolving Facility~~

~~The Amendment terminated the term loans thereunder in~~In connection with the refinancing described above and permitted the entry into and the lien and guarantees related to the SLR Credit Agreement. The guarantees and liens existing in connection with the Wells Fargo Credit Agreement remained in place upon the closingamendment of the transaction contemplated by the SLR Credit Agreement with respect to the revolving asset-based loans under the Wells Fargo Credit Agreement. The Wells Fargo Credit Agreement was also amended to add Financial Covenants consistent with the SLR Credit Agreement. The principal amounteach of the loans continue to bear interest based on the base rate or the SOFR rate, plus an applicable margin. The Amendment increased the margin applicable to SOFR loans and letters of credit to a range of 5.00% to 5.50% from a range of 1.75% to 2.25% in the Existing Credit Agreement (based on the maximum revolver amount) and the margin applicable to base rate loans to a range of 4.00% to 4.50% from a range of 0.75% to 1.25% in the Existing Credit Agreement (based on the maximum revolver amount). Borrowings under the Wells Fargo Credit Agreement are scheduled to mature, and all outstanding amounts thereunder will be payable on October 29, 2026, unless the maturity is accelerated subject to the terms set forth in the Wells Fargo Credit Agreement or if there is an earlier maturity of the SLR Credit Agreement.

~~Table of Contents~~

SOFR plus a margin of 7.75% to 8.25% (based on fixed charge coverage ratio). ~~As of December 31, 2022, our interest rate was 9.40% for the WF Revolver and 12.92% for the SLR Term Loan Facility.~~

The balance sheet classification of the borrowings under the ~~revolving~~ loan ~~facility~~facilities has been determined in accordance with ASC 470, Debt.

Off-Balance Sheet Arrangements

We have long lead times for inventory purchases and, therefore, must secure factory capacity from our vendors in advance. As of ~~December 31, 2022,~~June 30, 2023, we had approximately ~~$9.3~~$33.0 million, compared to ~~$39.8~~$12.1 million as of March 31, ~~2022~~2023 in non-cancellable market-based purchase obligations, primarily to secure additional factory capacity for inventory purchases in the next twelve months. Purchase obligations can vary from quarter-to-quarter and versus the same period in prior years due to a number of factors, including the amount of products that are shipped directly to Retail customer warehouses versus through Nautilus warehouses. The ~~decrease~~increase in purchase obligations was primarily due to strong inventory management as we continue to right-size inventory levels.

In the ordinary course of business, we enter into agreements that require us to indemnify counterparties against third-party claims. These may include: agreements with vendors and suppliers, under which we may indemnify them against claims arising from our use of their products or services; agreements with customers, under which we may indemnify them against claims arising from their use or sale of our products; real estate and equipment leases, under which we may indemnify lessors against third-party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.

The nature and terms of these indemnifications vary from contract to contract, and generally a maximum obligation is not stated. We hold insurance policies that mitigate potential losses arising from certain types of indemnifications. Management does not deem these obligations to be significant to our financial position, results of operations or cash flows, and therefore, no liabilities were recorded at ~~December 31, 2022.~~June 30, 2023.

Table of Contents

SEASONALITY

We expect our revenue from fitness equipment products to vary seasonally. Sales are typically strongest in our fiscal third quarter ending December 31 and fiscal fourth quarter ending March 31 and are generally weakest in our fiscal first quarter ending June 30 and fiscal second quarter ending September 30. We believe that consumers tend to be involved in outdoor activities during the spring and summer months, including outdoor exercise, which impacts sales of indoor fitness equipment. This seasonality can have a significant effect on our inventory levels, working capital needs and resource utilization.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our critical accounting policies have not changed ~~other than goodwill~~ from those discussed in our fiscal ~~2022~~2023 Form 10-K.

NEW ACCOUNTING PRONOUNCEMENTS

See Note 1 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 for a discussion of recent accounting pronouncements.

4335

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in our market risk as compared to the disclosures in Part II, Item 7A in our Annual Report on Form 10-K for the year ended March 31, ~~2022,~~2023, filed with the SEC on June ~~3, 2022.~~1, 2023.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

In accordance with Rule 13a-15 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer, the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). Based upon their evaluation of these disclosure controls and procedures, our management, including the Principal Executive Officer, Principal Financial Officer, and Principal Accounting Officer, have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report, our disclosure controls and procedures are effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the requisite time periods specified in the applicable Securities and Exchange Commission rules and forms, and that it is accumulated and communicated to our management, including our Principal Executive Officer Principal Financial Officer, and Principal Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the three-months ended ~~December 31, 2022,~~June 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

4436

Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

During the second quarter of fiscal 2022, we recorded a $4.7 million loss contingency related to a legal settlement involving a class action lawsuit related to advertisement of our treadmills. The settlement includes damages, a one-year free membership to ~~JRNY~~®~~, and administrative fees and was included as a component of General and administrative on our Condensed Consolidated Statements of Operations for the fiscal year ended March 31, 2022.~~

~~On June 27, 2022, the Court approved the settlement and no appeals were filed. We paid the settlement damages and related administrative fees during the second quarter of fiscal 2023.~~

As of the date of filing of this Quarterly Report on Form 10-Q, we were not involved in any material legal proceedings.

Item 1A. Risk Factors

We operate in an environment that involves a number of risks and uncertainties. The risks and uncertainties described in our ~~2022~~2023 Form 10-K are not the only risks and uncertainties to which we are subject, and there may be other risk and uncertainties that are not currently considered material or are not known to us that could impair our business or operations. If any of the risks described in our ~~2022~~2023 Form 10-K actually occur, our business, operating results and financial position could be adversely affected. There have been no material changes to the risk factors as set forth in our ~~2022~~2023 Form 10-K.

4537

Table of Contents

Item 6. Exhibits

The following exhibits are filed herewith and this list is intended to constitute the exhibit index:


Exhibit No.						Description

3.1						Amended and Restated Articles of Incorporation - Incorporated by reference to Exhibit A to Schedule 14A, as filed with the Commission on April 22, 2008.

3.2						Amended and Restated Bylaws - Incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K, as filed with the Commission on April 5, 2005.

3.3						Amendment to Amended and Restated Bylaws of the Company - Incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K, as filed with the Commission on January 31, 2007.




~~10.1~~4.1						~~Amendment to Nautilus, Inc. Amended and Restated 2015 Long-Term Incentive Plan -~~Form of Pre-Funded Common Stock Purchase Warrant – Incorporated by reference to Exhibit ~~4.6~~4.1 of our ~~Registration Statement~~Current Report on Form ~~S-8,~~8-K, as filed with the Commission on ~~August 22, 2022.~~June 15, 2023.

4.2						Form of Common Stock Purchase Warrant – Incorporated by reference to Exhibit 4.2 of our Current Report on Form 8-K, as filed with the Commission on June 15, 2023.

10.1						Form of Placement Agency Agreement by and between the Company and Roth Capital Partners, LLC, dated June 15, 2023 – Incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K, as filed with the Commission on June 15, 2023.

10.2						~~Credit~~Form of Securities Purchase Agreement ~~dated November 30, 2022,~~– Incorporated by ~~and between Nautilus, Inc. and Crystal Financial LLC D/B/A SLR Credit Solution.~~reference to Exhibit 10.2 of our Current Report on Form 8-K, as filed with the Commission on June 15, 2023.

10.3						Amendment to Credit Agreement dated ~~November 30, 2022,~~July 28, 2023, by and between Nautilus, Inc. and Crystal Financial LLC D/B/A SLR Credit Solutions.

10.4						Amendment to Credit Agreement dated July 28, 2023, by and between Nautilus, Inc. and Wells Fargo Bank, National Association.
31.1						Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.

31.2						Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.

32.1						Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities and Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS						XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH						XBRL Taxonomy Extension Schema Document

101.CAL						XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF						XBRL Taxonomy Extension Definition Linkbase Document

101.LAB						XBRL Taxonomy Extension Label Linkbase Document

101.PRE						XBRL Taxonomy Extension Presentation Linkbase Document

* Indicates management contract, compensatory agreement or arrangement, in which our directors or executive officers may participate.

4638

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	NAUTILUS, INC.
	(Registrant)

~~February~~August 9, 2023	By:	/S/ James Barr IV
Date		James Barr IV
		Chief Executive Officer


	NAUTILUS, INC.
	(Registrant)

~~February~~August 9, 2023	By:	/S/ Aina E. Konold
Date		Aina E. Konold
		Chief Financial Officer

4739



	As of December 31, 2022
	Operating leases		Finance leases
Remainder of fiscal 2023	$	1,011	$	29
2024	5,532		120
2025	5,599		120
2026	4,517		120
2027	2,359		60
Thereafter	5,796		—
Total undiscounted lease payments	24,814		449
Less imputed interest	(3,162)		(17)
Total lease liabilities	$	21,652	$	432


	Foreign Currency Translation Adjustments		Accumulated Other Comprehensive (Loss) Income
Balance, September 30, 2022	$	(2,607)	$	(2,607)
Current period other comprehensive loss before reclassifications	923		923

Net other comprehensive loss during period	923		923
Balance, December 31, 2022	$	(1,684)	$	(1,684)